Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 May 27.
Published in final edited form as: Circ Cardiovasc Imaging. 2022 Feb 17;15(3):e000075. doi: 10.1161/HCI.0000000000000075

Imaging and Surveillance of Chronic Aortic Dissection: A Scientific Statement From the American Heart Association

Dominik Fleischmann 1, Rana O Afifi 2, Ana I Casanegra 3, John A Elefteriades 4, Thomas G Gleason 5, Kate Hanneman 6, Eric E Roselli 7, Martin J Willemink 8, Michael P Fischbein 9, on behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Clinical Cardiology; and Council on Cardiovascular Surgery and Anesthesia
PMCID: PMC13204962  NIHMSID: NIHMS2161549  PMID: 35172599

Abstract

All patients surviving an acute aortic dissection require continued lifelong surveillance of their diseased aorta. Late complications, driven predominantly by chronic false lumen degeneration and aneurysm formation, often require surgical, endovascular, or hybrid interventions to treat or prevent aortic rupture. Imaging plays a central role in the medical decision-making of patients with chronic aortic dissection. Accurate aortic diameter measurements and rigorous, systematic documentation of diameter changes over time with different imaging equipment and modalities pose a range of practical challenges in these complex patients. Currently, no guidelines or recommendations for imaging surveillance in patients with chronic aortic dissection exist. In this document, we present state-of-the-art imaging and measurement techniques for patients with chronic aortic dissection and clarify the need for standardized measurements and reporting for lifelong surveillance. We also examine the emerging role of imaging and computer simulations to predict aortic false lumen degeneration, remodeling, and biomechanical failure from morphological and hemodynamic features. These insights may improve risk stratification, individualize contemporary treatment options, and potentially aid in the conception of novel treatment strategies in the future.

Keywords: AHA Scientific Statements, aortic diseases, aneurysm, dissecting, chronic disease, computed tomography angiography, multimodal imaging


Chronic aortic dissection has received little public or scientific attention compared with the dramatic events associated with acute aortic dissection.1,2 An increasing number of patients survive the acute phase of the disease and outlive the initial hospitalization for many years.37 Late complications, driven predominantly by chronic false lumen degeneration and aneurysm formation, often require surgical, endovascular, or hybrid interventions to treat or prevent aortic rupture. The requirement for continued, lifelong surveillance and specialized medical and surgical care for these complex patients represents a growing health care burden.8

Imaging plays a central role in the surveillance of patients with chronic aortic dissection. Monitoring the inevitable degeneration and aneurysmal dilatation of any residual aortic false lumen is critical for clinical decision-making and timing of interventions. Accurate aortic diameter measurements and systematic documentation of diameter changes over time and across imaging modalities pose technical and practical challenges that have not been adequately addressed in the literature. In this scientific statement, we systematically examine those challenges and present state-of-the-art imaging and measurement techniques that can be assembled into a standardized reporting system for patients with chronic aortic dissection.

In addition to its established role in the surveillance of patients with chronic dissection, modern imaging provides new and potentially important insights into the pathophysiology, hemodynamics, and mechanobiology of chronic aortic dissection. Imaging and computer simulations of blood flow allow patient-specific estimates of luminal pressures and wall tension.9,10 Wall tension directly drives false lumen expansion, ultimately leading to rupture, if it exceeds the remodeling capability and mechanical strength of the cellular and extracellular matrix constituents of the aortic wall.11 Understanding the complex interplay among morphological, hemodynamic, and biomechanical factors is a prerequisite for developing risk prediction models, for personalizing contemporary treatment options, and for conceiving and developing new treatment strategies.

EPIDEMIOLOGY AND ANATOMIC SPECTRUM

Although aortic dissection typically presents as an acute event with high mortality, aortic dissection is inherently a chronic disease. Medial degeneration is a prerequisite for aortic dissection to occur in most if not all patients and likely precedes the acute event by many years.12 Survivors of the acute event may live with the long-term sequelae of a dissected aorta for many years.

Originally, chronic aortic dissection was defined as the period after the first 14 days after onset of symptoms13 because most dissection-related complications occur within this time.14,15 A refined, contemporary classification subdivides the phases of aortic dissection into a hyperacute phase (first 24 hours) within the acute phase (up to 14 days after onset), followed by a subacute phase (15–90 days after onset) and chronic phase (>90 days after onset).16,17

Prevalence and Economic Impact

The prevalence of patients living with chronic aortic dissection in the United States is unknown and difficult to ascertain. This is an important gap in our knowledge and limits our ability to estimate the long-term quality of life and cost-effectiveness of evolving, personalized treatment or prevention strategies. In the first postevent year alone, the costs of care for the relatively small population of patients with chronic aortic dissection are substantial compared with the general population.8 The cumulative expenses for long-term specialty care, rehabilitation, surveillance, and preoperative and postoperative imaging, combined with frequent readmissions for elective or emergency surgical or endovascular repair, are likely to further escalate over time. Unfortunately, actual health care cost data beyond the first year after index hospitalization are not readily available.8

A rough approximation of the prevalence of chronic aortic dissection, assuming a conservative incidence rate of 4 to 6 per 100 000 per year1821 and conservatively assuming an average survival of 7 years for all subgroups, suggests a prevalence of 28 to 42 per 100 000 or 92 000 to 138 000 survivors of acute dissection in the United States (Figure 1). This corresponds well to the age-adjusted prevalence of 26 per 100 000 that is based on hospital administrative data in Manitoba, Canada, which has a reported incidence of acute dissections of 3 per 100 000 per year.29 For radiologists and others who routinely interpret vascular computed tomography (CT) studies, these numbers imply that many more CT scans are performed during the chronic than the acute phase of aortic dissection. The much larger proportion of chronic versus acute phase clinical imaging studies is illustrated in a small cohort of 47 patients with uncomplicated type B dissection occurring between 2003 and 201230 who were followed up for up to 17 years (Figure 2). In addition to their 47 baseline scans, these patients underwent a total of 363 follow-up scans, or 7.7 follow-up scans per patient.

Figure 1. Derivation of the anatomic spectrum of chronic aortic dissection.

Figure 1.

Flow diagram (left) and corresponding distribution charts (pie charts, right) illustrate how differences in survival transform the anatomic spectrum from acute to chronic aortic dissection. Patients are stratified by anatomic spectrum (type A vs type B), clinical course (for type B, complicated vs uncomplicated), and treatment (medical vs open or endovascular surgery). Approximately 60% of early survivors have surgically repaired type A dissections; 25% have uncomplicated type B dissections; and 15% are survivors of complicated type B dissections. This distribution likely persists given the comparable midterm and long-term survival between surgically repaired type A and medically or surgically managed chronic type B aortic dissections. Post-op TAAD indicates postoperative type A aortic dissection; TEVAR, thoracic endovascular aortic repair; and Tx, treatment. Flowchart based on International Registry of Acute Aortic Dissection registry (Pape et al22) and Registry of Acute Aortic Syndrome-II registry (Evangelista et al6) data, differential survival of type B dissections from Charilaou et al23 and Afifi et al,24 and midterm and long-term survival data from others.3,4,7,2428

Figure 2. Computed tomography (CT) scans in 47 patients with aortic dissection.

Figure 2.

Diagram plots all baseline (n=47; red dots) and follow-up CT scans (n=363; black dots) performed in a cohort of 47 consecutive patients (y axis) with an uncomplicated type B aortic dissection between January 2003 and December 2012 who were followed up in an aortic surveillance program until August 2020 over time (x axis). A small number of scans were performed before the index events (patients with known aneurysms or connective tissue disease [circles]).

Anatomic Spectrum of Chronic Aortic Dissection

The spectrum of patients living with chronic aortic dissection at a given point in time reflects the cumulative outcomes of multiple past events and depends on (1) the initial spectrum of the disease, (2) the differences in survival between groups, and (3) the outcomes of any surgical or endovascular interventions. Figure 1 illustrates the changing spectrum of disease from acute to chronic aortic dissection for a putative contemporary cohort of patients with chronic aortic dissection. Any recent changes in management or outcomes will be reflected in future chronic aortic dissection cohorts for years to come.

The largest group of patients with chronic aortic dissection (≈60%) are patients with surgically corrected ascending (Stanford type A) dissection with a persistent false lumen distal to the surgical repair (Supplemental Video). In the acute phase, the proportion of type A dissections is even higher, up to 75%,18 but not all patients survive. Patients with nonoperated type A dissection rarely live past the acute event; hence, chronic dissections of the ascending aorta are exceedingly rare. A small subset of patients with type A dissection limited to the ascending aorta (DeBakey type II, 10% in the International Registry of Acute Aortic Dissection31) are theoretically cured if the entire dissected segment is resected and no residual false lumen remains. No sustained benefit of type II morphology has been conclusively demonstrated, however.31 In the majority of surgically treated patients with type A dissection (DeBakey type I, 90%), the false lumen extends beyond the ascending aorta. The in-hospital mortality for acute type A dissection has been reported to be between 22% and 47%.3,5,6,19,22,32 In tertiary high-volume referral centers for aortic diseases, the surgical mortality for ascending and hemiarch replacement with or without root replacement is as low as 10% to 20%.3335 The subsequent midterm survival of surgically corrected ascending dissections at 1, 3, and 5 years is remarkably good at 95%, 93%, and 89%, respectively.4,7,36

Approximately one-third of acute dissections are Stanford type B, defined as dissections not involving the ascending aorta. Patients with uncomplicated type B dissection, that is, those without signs of rupture, rapid expansion, or branch vessel malperfusion37 (≈60%–70% of type B dissections) can be safely managed medically.24,36 The in-hospital mortality of these patients is extraordinarily low (0%–2.2%).23,24 Almost all patients with initially uncomplicated type B dissection therefore progress to the chronic phase, at which point they represent the second largest fraction (≈25%) of patients with chronic dissection. Complicated type B dissections (ie, those requiring urgent endovascular or surgical repair for aortic rupture, rapid expansion, or branch vessel malperfusion, as well as those patients too sick to undergo an acute intervention) represent ≈30% to 40% of type B dissections. The in-hospital mortality of these patients is unsurprisingly higher (≈20%).6,24 The survivors of this group include patients treated successfully with surgical or endovascular approaches and represent ≈15% of patients with chronic dissection. This percentage may change as a result of the current trend of using thoracic endovascular aortic repair (TEVAR) earlier in patients with uncomplicated acute or subacute type B dissections (Figure 1).38,39

The proportion of patients with chronic dissection who require ≥1 elective or urgent surgical or endovascular interventions increases over time in all groups. Although the occurrence of late complications and the need for emergency or elective intervention are the competing risks that each of these patients must face, many patients continue to live beyond these events. The long-term survival of patients with type A dissection (65%–89% after 5 years and 45%–65% after 10 years, respectively)3,4,7,25,27,28,36 is comparable to that of patients with type B dissection (84% after 5 years in patients with endovascular treatment; 71% after 5 years and 35%–69% after 10 years in medically managed patients).26,40,41

In addition to classic aortic dissection, 2 dissection variants, intramural hematoma42 and limited intimal tears,43,44 also may evolve into the equivalent of a chronic aortic dissection, leaving those patients at risk for subsequent expansion of the false lumen–equivalent, thinned outer aortic wall of these respective lesions.45

PATHOPHYSIOLOGY

Several alterations occur over time in the dissected aorta. Above all, the dissected aorta grows more rapidly than the nondissected aorta (3.1 mm/y versus 0.5 mm/y).46 Recent studies from multiple centers have confirmed these estimates, revealing growth rates of 2.3 to 4.1 mm/y.4750 A detailed study from the Aortic Institute at Yale University showed that growth during the first few days after aortic dissection is rapid but decreases substantially by 30 days to a slow but inexorable growth (Figure 3).51 In the same study, Peterss and colleagues51 revealed that the initial remodeling phase of the outer false lumen aortic wall is characterized pathologically by a high grade of cellular destruction in the aortic media, followed by substantial fibrosis in the chronic phase. In the absence of intact medial smooth muscle cells, adventitial fibroblasts remain as the primary cell population responsible for restoring and maintaining the structural integrity of the outer wall of the aortic false lumen.11

Figure 3. Morphological changes in aortic dissection.

Figure 3.

Orthogonal cross sections through the descending thoracic aorta at baseline (day 1) and 3 months, 6 months, 3 years, 8 years, and 9 years after the acute event. In the acute phase, the dissection flap (arrowheads) is highly mobile but becomes less mobile at 3 months and thicker and immobile after 6 months. The false lumen degenerates and becomes aneurysmal over time. The maximum aortic diameter increases from 39 to 43 mm in the first 6 months (annualized growth, 8 mm/y) and after 9 years becomes 55 mm (annualized growth, 1 mm/y from 6 months–9 years). False lumen thrombus (Thr.) is evident in years 8 and 9.

Similar pathological changes alter the dissection flap over time, which becomes thicker, fibrotic, and less mobile. The increasing stiffness of the dissection membrane increases pressure gradients between the true lumen and false lumen.10

Late Complications

In addition to the common but gradual development of false lumen aneurysms large enough to warrant elective repair, patients with chronic aortic dissection remain at risk for less common but acute and potentially lethal events requiring emergency intervention.30

Emergency Late Complications

Approximately 6% of patients with chronic dissection require an emergency intervention to treat new limb or mesenteric ischemia.41 New dissections or redissections occurred in ≈5% of patients in 2 single-center studies.52,53 New type A dissections in patients with chronic type B dissections occurred in 3.6% of medically managed patients, 4.3% of patients undergoing open aortic surgery, and 6.9% of patients with TEVAR.52 Acute redissection of a chronically dissected distal aorta, resulting in a new, third flow channel, is strongly associated with Marfan syndrome (21.5% versus 3.1%).53 Ensuing further thinning of the already dissected wall requires prompt intervention (Supplemental Figure 1). The most feared complication, late aortic rupture, is reported in 3% to 18%.5456 However, the actual rate is difficult to establish because, in most patients undergoing surveillance who die suddenly, a cause is not identified.

Aneurysm Formation

Aneurysms develop in 34% to 38% of patients with chronic type B aortic dissection26,55,56 and in up to 49% of patients with residual chronic aortic dissection in the distal aorta after type A aortic repair.57 Aneurysm formation is the primary reason for reoperations in patients with chronic aortic dissection.55 Reoperation rates in residual chronic type A aortic dissection range between 9% and 27.5%, with some patients requiring >1 reintervention.27,54,57 Intervention-free survival in type B aortic dissection is reported to be between 41% and 66%, depending on complication status at the initial event.24,55,56

Hemodynamics and Mechanobiology

The complex interplay among morphological, hemodynamic, and biomechanical factors contributing to false lumen degeneration and aneurysm formation is incompletely understood. This is a critical gap in our knowledge that impedes our efforts to solve important problems. First, we currently lack reliable prediction models to guide treatment in patients with uncomplicated type B aortic dissection.58 We possess a wealth of imaging data attesting to the vast individual variation of aortic dissection manifestations. However, without understanding how an individual’s constellation of dissection features translates into false lumen pressure, wall tension, and growth, we may not be able to synthesize a reliable prediction tool that can be clinically tested. Second, only by understanding the interaction of morphology, hemodynamics, and biomechanics will we be adequately equipped to anticipate the effect of interventions on these parameters, which control the long-term fate of the false lumen and thus patient outcome. A broader interdisciplinary approach to the conundrum of the false lumen may help to develop novel therapies.

New insights are currently emerging from the combination of imaging data (3-dimensional [3D] and 4-dimensional morphological data from CT,30,59,60 flow data from magnetic resonance imaging [MRI]61), computer simulations (computational fluid dynamics,62 fluid-structure interaction9,10,63), bench-top and in vitro phantom studies,64,65 biomechanical bench testing,66 and numerical modeling of aortic wall constituents,6668 as well as from the field of mechanobiology.11,69 A graphical synopsis of factors contributing to false lumen dilatation is shown in Figure 4. The key points are as follows:

Figure 4. Pathophysiology and biomechanics of chronic aortic dissection.

Figure 4.

Schematic illustrates the complex interplay between morphological features derived from imaging, with hemodynamic, biomechanical, and mechanobiological factors leading to false lumen degeneration and aneurysm formation and ultimately rupture in chronic aortic dissection. See text for details. CFD/FSI indicates computational fluid dynamics/fluid structure interaction; ECM, extracellular matrix; FL, false lumen; PIT, primary entry tear; and TL, true lumen.

  • The outer wall of the false lumen is a load-bearing structure derived from the aortic adventitia left intact after the initial delamination of the intima and variable amounts of the media layer of the aortic wall.

  • Restoration of false lumen wall strength and homeostasis is maintained by adventitial myoblasts/fibroblasts, which are sensitive to changes in wall tension (mechanosensing), responding with proliferation and increased synthesis and cross-linking of collagen. This is noticed at late surgical intervention as a strong, leathery thickening of the adventitial layer.

  • Even a marginally inadequate tissue response to wall tension can enter a vicious cycle in which any increase in false lumen diameter proportionally translates into an ever-increasing wall tension, resulting in continuous growth of aortic diameters over time.

  • Once the restorative capabilities are exhausted and the wall tension exceeds the tensile strength, structural failure and aortic rupture ensue. This occurs with increasing frequency at maximum aortic diameters >55 to 60 mm.

  • The wall tension of the false lumen is not only determined by its thickness and geometry (or its clinical proxy, the maximum aortic diameter) but is also directly proportional to the hydrostatic pressure in the false lumen.

  • The false lumen pressure is a function of true lumen pressure, modulated by blood flow alterations specific to morphological dissection features. Although the systolic pressure is always equal or higher in the true lumen, an uninhibited inflow into the false lumen (enabled by a large enough primary entry tear), combined with high outflow resistance from the false lumen, results in a reversal of the pressure gradients in diastole. Thus, the diastolic and mean pressures can be higher in the false lumen than in the true lumen.

  • False lumen outflow resistance is related to the number of branch vessels draining the false lumen (more draining branches decrease resistance) and to the number, size, and location of communications between the true and false lumens across the dissection flap (fenestrations, re-entry tears).

  • The dissection membrane also modulates the pressure gradients between true and false lumens. A mobile flap decreases and a stiff flap augments the pressure differences between the true lumen and the false lumen.

MANAGEMENT OF CHRONIC AORTIC DISSECTION

Watchful Waiting

The mainstay of management of chronic aortic dissection is (1) antihypertensive therapy, including anti-impulse therapy with β-blockade and afterload reduction; (2) lifelong surveillance with imaging; and (3) timely repair once the dissected aorta becomes significantly aneurysmal.37,70

Anti-impulse therapy was pioneered by Wheat et al71 in 1965 to prevent dissection progression in the most acute phase. The effectiveness of combination β-blocker and afterload reducing drugs treatment is unquestioned in both the acute and chronic phases of aortic dissection.72 It is important to note that unopposed afterload reduction can lead to unwanted reflex tachycardia.

The rationale for the traditional “watchful waiting” strategy, conceived in the pre-endovascular era, is based on the need to balance the expected morbidity and mortality of preemptive open surgical repair against the risk of fatal aortic rupture. Currently accepted size thresholds were established from the 1997 landmark work of Cody and colleagues46 from Yale University demonstrating rapidly increased risk of rupture once the aneurysmal aorta exceeds 6 cm (Supplemental Figure 2). The morbidity and mortality associated with contemporary surgical and endovascular repair are evolving; however, and the optimal treatment and timing for intervention in patients with chronic aortic dissection are becoming less certain.

Current guidelines, published between 2010 and 2017, consistently recommend intervention in patients with aneurysms >6.0 cm (Class I), with TEVAR to be considered in high-risk patients or nonsurgical candidates (Class IIa).37,70,73 Open surgical repair is recommended in patients with connective tissue disease with an aneurysm diameter of 5.0 to 5.5 cm (Class I or IIa). TEVAR may be considered at that same 5.5-cm-diameter threshold as a Class IIb indication in more recent guidelines.37,73 Of note, all pertinent guidelines acknowledge the poor quality of evidence for TEVAR recommendations in patients with chronic dissection and the lack of better evidence-based risk stratification and stress the need for individualized decision-making, ideally by a multidisciplinary team of experts.37,70,7376

The time intervals suggested for surveillance imaging in patients with chronic aortic dissection vary across guidelines and should be tailored for individual patients.37,70,73,75,76 Considering the natural course and reported growth rates of the dissected aorta,46,51,77 several reasonable follow-up regimens have been proposed for different treatment groups, preferably beginning with a baseline predischarge scan. After surgical repair, patients could be followed up after 6 and 12 months and annually thereafter. If a moderate-sized aneurysm remains relatively stable over time, subsequent longer follow-up intervals of 1.5 to 3 years are reasonable.70 In medically managed uncomplicated type B dissection, 1 additional earlier scan, for example, at 3 months, may reveal important changes occurring in the subacute phase, when the dissected aorta remains amenable to early TEVAR. Earlier follow-up imaging at 30 days is sometimes recommended to identify potential early complications, followed by routine 6-month and 12-month follow-up.37,73,75,76 Continued annual imaging is suggested thereafter, even if the aorta stabilizes after TEVAR. If growth or other complications are detected, shorter follow-up intervals may be required in all treatment groups.70 Eventually, most patients with chronic aortic dissection develop substantial aortic dilatation, especially in the proximal descending aorta, just beyond the left subclavian artery. These patients can be operated on safely with either open aortic replacement or endovascular therapy, depending on anatomy, age, and connective tissue disorder diagnosis.23

Surgical Treatment of Chronic Aortic Dissection

Open surgical repair remains the dominant method of managing chronic aneurysmal thoracoabdominal aortic dissections given (1) the limitations of current endovascular techniques, including adequacy of landing zones, the noncompliant dissection flap, and the uncertain durability of TEVAR, and (2) the beneficial impact that advances in circulation management, cerebrospinal fluid drainage, neurocerebral monitoring, and perioperative management protocols have had on surgical outcomes.

Variability in the natural history of chronic descending aortic dissections demands careful monitoring by cardiovascular surgeons as part of a multidisciplinary team including vascular surgeons, cardiologists, and radiologists with interest and expertise in the management of aortic pathology. Acute ascending aortic dissections, despite proximal repair, often incur residual distal arch or descending and thoracoabdominal aortic dissections. Despite similarities to chronic type B aortic dissections, residual type A dissections often have different implications with respect to managing the aortic arch.

Indications for open operative intervention in uncomplicated chronic aortic dissections hinge primarily on aortic caliber, pathogenesis, and occasionally symptoms. Asymptomatic chronic thoracic and thoracoabdominal aortic dissections with a maximal orthogonal aortic diameter of 6.0 cm in patients without connective tissue disease warrant repair.37,46,70 Rapid growth rate also may be an indication for repair. Patients with connective tissue diseases and those with a family history warrant more careful consideration and may warrant earlier intervention (diameter of 5.0–5.5 cm).78,79 Griepp and colleagues80 have used a formula that predicts risk according to aneurysm size, age, and the presence of comorbidities such as renal insufficiency and emphysema.56 Operative morbidity risk with repair of aneurysmal chronic descending and thoracoabdominal aortic dissections is substantial and potentially includes respiratory insufficiency, renal failure, myocardial infarction, stroke, left vocal cord paralysis, wound infections, and paraplegia. The relative risk of complications imparted by chronic dissection in the context of thoracoabdominal aortic aneurysm replacement has not been distinctly determined by any of the large series. In the largest series (3309 cases) of thoracoabdominal aortic aneurysm repair by Coselli et al,81 36% of cases were operated on for chronic aortic dissection: Operative mortality was 7.5%; dialysis dependence rate was 5.7%; and paraplegia rate was 2.9%. Smaller recent reports on outcomes in this specific patient population are similar with mortality rates ranging from 5.8% to 11%.8289 There remains no consensus among the large thoracic aortic centers around the world as to the optimal operative repair strategy for chronic aneurysmal thoracoabdominal aortic disease. Limiting the repair to the aneurysmal segment rather than the entire dissected aorta reduces the risk of complications and paraplegia, but several techniques have been successful in delivering acceptable morbidity and mortality for this difficult problem. The 2 centers with the lowest reported mortality for thoracoabdominal aortic aneurysm repair in the context of chronic dissection have used deep hypothermic circulatory arrest for their technique.83,90

Endovascular Therapy

Open surgical repair may be too morbid for some patients with chronic dissection and is often postponed for too long.88,91 TEVAR provides another mechanical treatment option that has been increasingly used because of the low acute risk compared with open repair and the potential to reduce aortic mortality and reoperations compared with medical therapy.92,93 However, TEVAR faces anatomic and morphological limitations to successfully treating this disease, particularly in the chronic stage.9497

A TEVAR-based strategy seeks to seal intimal entry tears with device fabric and to expand the true lumen by outward radial force of the stents. In patients with chronic aortic dissection and aneurysm, covering entry tears is an important treatment objective to promote thrombosis and false lumen remodeling.97 A patent false lumen has been associated with decreased survival and increased risk of reintervention.98 TEVAR of chronic dissection may promote false lumen thrombosis at a variable rate over time. It has been shown, however, that thrombosis needs to be complete to reverse the natural history of disease.96,97

In most patients with type B aortic dissection, the proximal entry tear can be covered with an endograft. Coverage of the left subclavian artery is often necessary to achieve an adequate proximal landing zone. Patients with dissections limited to the descending thoracic aorta (DeBakey type IIIA) often exhibit an adequate landing zone in the distal descending thoracic aorta.41,99 Unfortunately, most dissections extend across the visceral branch origins. Re-entry tears and fenestrations of the dissection flap within the abdominal aorta frequently maintain false lumen perfusion and pressurization. Increased number and size of distal re-entry tears and false lumen origin of branch vessels are associated with persistent false lumen flow.97,100

Several strategies can be used to facilitate a distal seal of an excluded false lumen aneurysm to prevent retrograde filling such as percutaneous “cheese-wire” flap fenestration, balloon septum rupture (Knickerbocker technique), laser aortic septotomy, or placement of coils of plugs (candy plug technique) for false lumen embolization (Supplemental Figure 3). Additional endovascular therapies may require the use of bare stents to expand the true lumen with or without ballooning or the use of investigational or homemade branched devices.101111

Role of Imaging for TEVAR Planning and Follow-Up in Chronic Dissection

Endovascular treatment planning is typically based on preoperative CT angiography (CTA). A fundamental requirement for successful TEVAR is an adequate device landing zone of healthy aorta of at least 15 mm in length and between 18 and 42 mm in diameter that will allow a parallel lie of the sealing endograft. Predischarge, assessment of adequate device position, successful coverage of communications and tears, and assessment of branch vessels that can contain re-entry tears is important. Surveillance imaging is critical to monitor aortic dimensions, persistent false lumen patency, or thrombosis and any new complications. Adequate imaging assessment after TEVAR requires a delayed-phase scan to identify small leaks that slowly fill yet pressurize the false lumen.

Considerations in Patients With Connective Tissue Disease

There is limited information about the best strategy to manage chronic dissections in patients with a genetic predisposition to aortic diseases. Although dissections are more frequent and occur at a younger age in these groups than in the general population, the overall prevalence is low, challenging the design of comparative trials. Most available data come from registries and retrospective studies that have not examined determinants for interventions.

In an analysis of registry data, patients with the Marfan syndrome were more likely to have an intervention than medical treatment when presenting with an acute type B dissection.112 Although the reason for this was not specifically captured, a possible explanation is that patients with Marfan syndrome tend to have extensive aortic involvement,112,113 which may influence the decision. There was no difference in organ malperfusion.

Although endovascular procedures can be lifesaving in the acute setting in these patients, open surgery is preferred for chronic dissections because of the concern for retrograde dissection proximally, early graft failure attributable to tensile forces of the graft in an abnormal aortic wall, and increased need for reinterventions after endovascular repair.114

Information on chronic dissections in Ehlers-Danlos syndrome (vascular type) is even scarcer. A multicenter cross-sectional retrospective study of 86 patients115 reported 17 with aortic pathology treated by medical management; thus, the authors recommended intervention only for distinct complications. Open surgery is preferred over an endovascular approach on the basis of the risk of erosion or perforation at the landing zones of the endograft resulting from the fragility of the aortic wall.115117

IMAGING TECHNIQUE

Computed Tomography

CTA is the most commonly used modality for imaging of patients with acute and chronic aortic dissection.118120 State-of-the-art CT scanners are widely available and capable of acquiring high-resolution volumetric data sets that can be reformatted into a wide range of 2-dimensional and 3D angiographic images.

A typical imaging protocol includes an optional noncontrast scan for identification of surgical grafts and high-attenuation foci that can mimic pseudoaneurysm, followed by a 50- to 150-mL contrast medium–enhanced angiographic acquisition. Additional delayed-phase scans are required in post-TEVAR patients to assess for endoleaks and can help distinguish slow flow–related unenhanced regions in the false lumen from thrombus. Scan times for each acquisition range between 5 and 20 seconds. Measurements of the ascending aorta are more reliable when electrocardiographic gating is used to suppress cardiac pulsation artifacts,121 although the scan time of many modern scanners is short enough to render electrocardiographic gating less necessary. If retrospective electrocardiographic gating is used, CT images can be reconstructed and viewed over the entire cardiac cycle, adding a fourth dimension to CTA.

The effective radiation dose from a single arterial phase CT scan is ≈8 mSv (range, 2–20 mSv) and from a 3-phase scan is ≈25 mSv (range, 3–60 mSv).122,123 Even in the setting of lifelong surveillance with annual CT scans, the estimated excess risk of cancer attributable to CT radiation is low, between 0.43% and 0.65% for patients in their early 50s and even less in older individuals.122,124 For comparison, the lifetime risk of cancer is almost 100 times greater at 44%.125 The known benefits of a clinically indicated CT scan in the typical age group of patients with chronic dissection almost certainly exceed the uncertain and theoretical risks of imaging-related radiation exposure.

Magnetic Resonance Imaging

MRI is an accepted alternative to CTA for the assessment of patients with chronic aortic dissection.126,127 Advantages of MRI include lack of ionizing radiation,70 which may be a particularly important consideration in young individuals such as patients with Marfan syndrome in their 20s or 30s with near-normal life expectancy, especially before the aorta becomes dissected, substantially aneurysmal after dissection, or difficult to assess after serial interventions. Disadvantages of MRI compared with CT include a longer scan duration, lower spatial resolution, artifacts from implanted devices such as endografts or mechanical heart valves, and potential contraindications such as certain metallic implants.

A typical MRI protocol includes multiple sequences. Contrast-enhanced magnetic resonance angiography (MRA) with gadolinium-based contrast agents provides high-quality 3D data sets. Like CTA, MRA allows multiplanar evaluation to obtain orthogonal measurements. Recent advances in noncontrast MRA techniques have made this a viable alternative in patients with contraindications to gadolinium-based or iodinated contrast agents.128 The addition of phase-contrast imaging allows the assessment of blood flow and false lumen thrombosis.129

Four-dimensional flow MRI is an emerging technique that allows exquisite characterization of altered flow dynamics in both true and false lumens and quantification of parameters such as wall shear stress, which may have prognostic value.130133 Given the potential role of inflammation in the progression of aortic aneurysms, the recent integration of hybrid positron emission tomography/MRI systems may provide another avenue for simultaneous assessment of anatomic, physiological, and molecular imaging biomarkers.134

Echocardiography

Transthoracic echocardiography (TTE) is commonly performed in patients with chronic aortic dissection with concomitant dilatation of the unrepaired aortic root. In select patients, TTE and transesophageal echocardiogram (TEE) also can be useful to evaluate the dissection flap,37 to demonstrate communications between the true and false lumen, and to assess blood flow versus thrombus in the false lumen. TTE and TEE do not require contrast agents or ionizing radiation. The disadvantages of echocardiography are that not all aortic segments can be interrogated and TEE requires sedation.

TTE is noninvasive and allows evaluation of the aortic valve, root, and ascending aorta at each follow-up. In some patients, the arch can be visualized through the suprasternal view. The descending aorta is only occasionally visualized.135

TEE allows visualization of the aortic arch but requires sedation and has a blind spot in the distal ascending aorta caused by the interposition of the right tracheobronchial angle.135 For acute dissections, TEE has a high sensitivity (86%–100%) and specificity (90%–100%) compared with CTA.136 In chronic dissections, 3D TEE and 2-dimensional TEE have been compared with CT and were equivalent in locating and measuring the entry tear size, and they were better at detecting secondary tears.137

MEASUREMENT PRINCIPLES

The quintessential information sought from imaging studies in patients with chronic aortic dissections is aortic caliber. The maximum aortic diameter is strongly associated with the risk of aortic rupture and currently remains the predominant parameter for surgical decision-making.37,46,70,7376 Measurements of adjacent segments as potential landing zones, separate diameter measurements for true and false lumen, and access vessel size are also important for determining anatomic eligibility and treatment planning for endovascular repair.138

Despite its importance and the large number of measurements obtained every day in hundreds of patients with chronic aortic dissection, few specifics on how to perform and compare measurements of the dissected aorta can be found in the literature.119,120

Definition of Aortic Diameters

The aorta is a curved, tubular structure, often with a non-circular cross section, tapering from proximal to distal, while giving off multiple branch vessels. Aortic diameters refer to the cross-sectional distances obtained in a plane that is orthogonal to the aortic flow channel, often represented as its medial axis139 or aortic centerline. On a given orthogonal cross section, aortic diameters are expressed as the diameters of the long (major) axis and the short (minor) axis, respectively (Figure 5). The maximum aortic diameter is the largest of all major axis diameters on any of the aortic cross sections along the aorta.

Figure 5. Definition and measuring of the maximum aortic diameter.

Figure 5.

Maximum diameter is measured on double-oblique reformations oriented orthogonal to the aortic flow channel. Note the remarkable difference between the long-axis diameters between the transverse images (47 mm vs 54 mm). Major and minor axis diameters include the luminal thrombus if present. Ann indicates aortic annulus; bif, bifurcation; Darc, distal arch; Ddes, distal descending aorta; MidAsc, middle ascending aorta; Parc, proximal arch; Pdes, proximal descending aorta; SOV, sinus of Valsalva; and STJ, sinotubular junction.

In addition to the maximum aortic diameter, aortic measurements typically include diameters at predefined landmarks along the aorta such as the aortic root at the annulus, at the sinuses of Valsalva, and sinotubular junction, as well as select locations in the ascending aorta, in the aortic arch, and along the descending thoracoabdominal aorta.140,141

Measurement Technique

There is unanimous agreement that aortic diameters should be measured perpendicular to the aortic long axis.142,143 CTA and MRA data are 3D volumes consisting of stacks of narrow-spaced 2-dimensional slices. Obtaining the appropriate measurement plane in CTA and MRA therefore requires reformatting the data into so-called double-oblique images or multiplanar reformations (MPRs).

MPRs can be obtained either manually or with the assistance of (semi)automatically generated aortic centerlines. With the centerline method, perpendicular MPRs can easily be created, and distance measurements can be obtained along the aortic axis. The aorta can also be unfolded along its centerline as a straightened- or a curved-planar reformation, which also facilitates length measurements, in addition to diameters.144

In patients with chronic dissection, selecting the best MPR orientation becomes more difficult as the false lumen becomes larger and approaches the surgical size threshold. Asymmetry and stark differences in contrast enhancement between the true and false lumen, with or without the presence of false lumen mural thrombus, often preclude the use of the centerline method at this stage, whereas increasing tortuosity and kinking caused by aortic elongation pose a formidable challenge to manually selecting the best MPR orientation, even for experienced users. Selection of MPR location and orientation is likely the largest source of measurement uncertainty and discrepancies in patients with chronic dissection and false lumen aneurysms.

Aortic Measurements on Transverse Images

Axial images are commonly reviewed to obtain a first impression and approximate size of a patient’s aorta. It cannot be overstated, however, that transverse (axial) images are unsuitable to accurately determine the maximum aortic diameter.145 Incorrectly using the largest dimension of an oblong aortic cross section on axial images has been shown to overestimate vessel size by up to 6 to 7 mm on both CT and MRA.146,147 If an aortic diameter must be measured on axial images (eg, in an emergency or without CT data or 3D viewing capability), the short-axis diameter is a closer approximation of the true diameter and should be recorded.148,149 However, this approach may underestimate the true maximum aortic diameter in patients with an ellipse-shaped aneurysm.150,151 Viewing of coronal or sagittal images mitigates but does not eliminate this problem.

Reproducibility and Discrepancies

Although most of the literature and guidelines on imaging-based measurements of the aorta focus on the aortic root and thoracic or abdominal aortic aneurysms, several technical limitations and uncertainties also apply to chronic aortic dissection.

Cardiac Phase and Electrocardiographic Gating

Although echocardiographic diameter measurements are typically obtained in middiastole,143 there are no consistent recommendations for CT and MRI across multimodality guidelines with respect to the most appropriate cardiac phase for aortic assessment.143 Both the 2010 American College of Cardiology Foundation/American Heart Association guidelines and the 2020 International Society for Magnetic Resonance in Medicine recommendations suggest the use of electrocardiographic gating triggered to end diastole for the assessment of the aortic root.70,140

In chronic dissection, this is most relevant for patients with unrepaired root aneurysms. Aortic pulsation is typically small (1–2 mm) in patients with noncompliant aneurysmal aortas. The main reason for electrocardiographic gating is not to capture maximum dilatation (which would be during the short systolic phase) but to suppress the more pronounced translational motion of the aortic root and proximal ascending aorta attributable to ventricular contraction. Thus, diastolic reconstructions are favored for ECG-gated CT as well. Gating is a prerequisite for accurate aortic root and proximal ascending measurements but is not critical for the distal aorta.

Inclusion or Exclusion of the Aortic Wall

There is currently no clear consensus on whether the aortic wall should be included in aortic diameter measurements, although the difference may be several millimeters, particularly if there is atherosclerotic disease or mural thrombus.142,152

For TTE measurements of the aortic root, the 2010 American College of Cardiology Foundation/American Heart Association guidelines recommend using the internal diameter.70 The American Society of Echocardiography recommends measurement of the aortic root from the leading edge of the anterior wall to the leading edge of the posterior wall (leading edge to leading edge) on a parasternal long-axis view, thus including half of the aortic wall.153 Most of the normative data on aortic size in the literature were obtained with this technique, and this convention is used clinically in many centers.154156 A 2015 multisociety expert consensus statement recommends maintaining the use of the leading edge–to–leading edge technique because of the greater reproducibility of this approach.143

For CT and MRI, there also is no clear consensus.157 The 2010 American College of Cardiology Foundation/American Heart Association guidelines recommend measurement of aortic diameters between external surfaces on CT and MRI (outer wall to outer wall) given that lumen size may not reflect the true size of the aorta in the presence of intra-aortic thrombus, atheroma, aortic wall inflammation, or dissection.70,158 The outer wall technique also can be applied to noncontrast CT. In clinical practice, however, and in most research studies, the internal cross-sectional diameter is reported.152,159 The 2020 International Society for Magnetic Resonance in Medicine guidelines also recommend inner lumen–to–inner lumen measurements of the aorta on MRI.140

Patients with aortic dissection have 2 flow channels. The outer wall of the true lumen usually has normal wall thickness (≈1 mm), which is simply too thin to be resolved as a separate structure even on a high-quality CTA (≈1-mm3 voxel dimensions). The distinction between inner and outer contours is thus moot. The outer wall of the false lumen is initially even thinner and cannot be resolved either until it becomes >1 mm thick. The high-contrast interface between lumen and surrounding tissue is therefore a reasonable representation of diameter and can be detected automatically. Once mural thrombus occurs and obscures the interface between the (now thrombosed) lumen and the inner border of the aortic wall, it becomes necessary to use the outer aortic contour as a landmark. The resulting “error” of including 1 of the 2 walls in the total measurement is probably small, 1 to 2 mm.

A final example of inconsistency with respect to inclusion versus exclusion of the aortic wall can be found in TEVAR device sizing guidelines. Cook Medical (Bloomington, IN) bases its recommendations for the Zenith Alpha Thoracic Endovascular Graft on outer wall–to–outer wall dimensions,160 whereas W.L. Gore (Flagstaff, AZ) recommends sizing of its Conformable TAG Thoracic Endoprosthesis on the flow lumen (including thrombus), not the vessel wall.161

Differences Within and Between Imaging Modalities

Most studies comparing 2-dimensional TTE with CT and MRI found that TTE significantly underestimates aortic root diameters compared with CT162164 and MRI,163166 likely related to off-axis image acquisition and root asymmetry. On the other hand, 3D TTE correlates well with CT.165 Several studies also have demonstrated that abdominal ultrasound systematically underestimates the size of abdominal aortic aneurysms by ≈1 to 3 mm compared with CT.167171

In the nondissected thoracic and abdominal aorta, the agreement between diameter measurements obtained with CTA and MRA is good when the same analysis technique is used,168171 and interobserver agreement is excellent.163,164,172 No such data are available for chronically dissected distal aortic segments, however. It is reasonable to assume that agreement is less, perhaps more similar to the interobserver and intraobserver variability of CT for abdominal aortic aneurysms, reported at ≈5 and 3 mm, respectively.168170

Implications for Serial Measurements

There is broad consensus that an identical imaging technique be used for serial aortic imaging.37,70,143 Given the degree of variability in measurements, a recent expert consensus statement recommended caution in interpreting apparent changes in aortic diameter ≤3 mm by ECG-gated CT and ≤5 mm by nongated CT.143 Aortic growth estimates based on small apparent diameter increases over short time intervals (≤6 months) also should be treated with caution given the potential implication for surgical repair.

This represents a considerable degree of uncertainty given the clinical implications for patients with chronic aortic dissection. It is currently unknown whether including details of the measurement technique (eg, gating, inclusion of wall, orientation of measurement plane), as proposed by Freeman et al,152 in the radiology report improves interpretation of imaging results by the treating physician. Selecting identical anatomy and measurement planes may be the most important steps to reduce overall measurement discrepancies in patients with chronic dissections and aneurysms; however, this has not been formally studied.

False Lumen Measurements

Separate measurements of true and false lumen diameter, area, or outer aortic wall circumference have been used in research but are not routinely obtained in patients with aortic dissection.59,119 Diameter and area measurements (but not circumference) are affected by the deformation of the dissection flap over the cardiac cycle.30,59 A proximal descending aorta false lumen diameter >2.2 cm has been associated with late complications in patients with uncomplicated type B aortic dissections.173 Volumetric measurement techniques may be more reliable for documenting small changes over time and have been used to define positive and negative remodeling in device trials.96,174

SURVEILLANCE IMAGING

Providing technically accurate aortic measurements in patients with chronic aortic dissections is a prerequisite but is not nearly enough for adequate surveillance imaging, for which a large number of patients with numerous follow-up studies are routinely encountered.

Comparisons With Priors, Including Older and Outside Imaging

In patients with chronic aortic dissection, it is imperative that each imaging study is carefully compared with priors, including studies done at other facilities.175,176 Ideally, all prior studies should be reviewed before a therapeutic decision is made.37 At a minimum, the most recent prior study and the earliest (baseline) study should be compared with the current study.

Serial Measurements and Comparisons

Serial measurements should always be obtained at the same anatomic location and identical orientation along the aorta, particularly when the diameters approach the intervention threshold. This requires direct side-by-side comparisons of original image data sets, typically done on a 3D workstation, and can be a time-consuming task in patients with elongated and tortuous dissected aortas (Figure 6). It cannot be overemphasized that comparing independently reported measurements without reviewing the actual images is highly unreliable and can lead to spurious aneurysm growth or missing significant enlargement, with potentially serious consequences.

Figure 6. Serial imaging: spatial alignment of orthogonal measurement planes.

Figure 6.

Baseline (left) and 3-month, 6-month, and 12-month (right) follow-up computed tomography scan of a patients with type A dissection treated with ascending aortic repair. Accurate growth measurement requires double-oblique images to be obtained at the same location and orientation along the aorta. A indicates anterior; F, feet; H, head; L, left; P, posterior; and R, right.

None of the above requirements are easily accommodated within a busy imaging service. First, it is necessary to clearly identify the patients for whom elaborate measurements are requested. The full gamut of necessary measurements and documentation is often too time consuming to be routinely carried out by the interpreting physician, notably if similar measurements also need to be performed on prior images at the time of interpretation. Prior images are not always easily available, and often no mechanism to review, analyze and report outside imaging studies exists.

These predicaments can be overcome by building a dedicated surveillance program made up of agreed-on measurement, comparison, and reporting protocols at its core. Specific recommendations for structuring and implementing a surveillance program are currently not available, and although there is little doubt that better standardization has benefits, we do not have any evidence that implementation of a surveillance program improves outcomes. The initial investment of time, effort, and resources to build the logistical framework is considerable and may be warranted only for aortic centers specialized in the lifelong care for patients with chronic dissection and other aortic diseases.

Imaging Surveillance Program

At the core of any dedicated aortic imaging surveillance program is the standardization of the measurement protocol and the development of a mechanism how to perform, store, and retrieve comparison measurements (including for outside studies). This requires that a patient’s measurements are obtained at 1 point in time and are available at all subsequent visits. This way, a patient’s surveillance record only needs to be updated with the latest, carefully obtained side-by-side measurements, except if a patient enters the system at a later stage or at the time of program initiation. Reporting standards also need to be agreed on, including how the pertinent information can be incorporated into or added to the radiological report and the patient’s medical record. Additional logistics related to prioritizing measurements for clinic visits, ordering and billing of measurements on outside studies, and quality assurance need to be developed in close collaboration between radiologists, cardiothoracic and vascular surgeons, cardiologists, and vascular specialists and their respective teams. Last, close interaction between clinical and postprocessing teams to reconcile any discrepancies and to improve the system is important for maintaining a vital service.

The execution of the core tasks is best implemented in a 3D laboratory or equivalent where trained technologists perform measurements with consistent quality. A sample measurement protocol is provided in Supplemental Figure 4. Most large institutions housing an aortic center most likely also have a 3D laboratory or at least the functionality of such a laboratory in their imaging departments.

Reporting and Visualization

The key information, that is, the validated diameter measurements compared with corresponding prior measurements, is best reported in a table rather than in text format augmented by a graphical display that better visualizes the information for physicians, staff, and patients. A simple example is shown in Figure 7, in which aortic diameter measurements at different time points are listed in a table (a simple spreadsheet suffices) and plotted graphically.

Figure 7. Surveillance imaging measurement report.

Figure 7.

A, For each baseline and follow-up imaging study, orthogonal aortic diameter measurements are entered into a spreadsheet or database. Note that in this patient the maximum diameter is approximately halfway between 2 standard aortic landmarks, the proximal (Pdes) and distal (Ddes) descending thoracic aorta. B, Diameters (y axis) are also plotted graphically against anatomic landmarks along the aorta (x axis). Time is color coded, with the baseline study plotted in green, the second-to-last study in blue, and the latest study in red.

An infinite range of alternative methods can be used to visualize the relevant information, including interactive tools switching between simple diameter plots and displays emphasizing the time axis.177 Several symbols or cartoon representations for differently treatment segments (surgical grafts, endografts) also can be displayed.178 Currently, these techniques are custom made and developed out of necessity at academic institutions, but similar to other applications such as planning for abdominal endovascular aortic repair or transcatheter aortic valve replacement, commercial tools are likely to become available eventually.

RISK STRATIFICATION AND NEW DEVELOPMENTS

After decades of management choices limited to watchful waiting followed by elective open repair in the chronic phase, new treatment options during the acute or subacute phase have become available that may reduce the risk of late complications in patients with aortic dissection.95,179,180 Patient selection and choice of the best therapy remain a challenge, however. For instance, identifying patients who are most likely to benefit from preventive TEVAR in type B dissection requires the ability to predict the time course of the false lumen dilatation. Likewise, considering alternative treatment options requires the ability to forecast the effect of each intervention on the fate of a patient’s aorta.

Several attempts to improve risk stratification in patients with aortic dissection have been made over the past years. A major focus of interest and ongoing matter of debate is risk stratification of patients with uncomplicated type B dissection. Initial strides toward predicting and simulating the effects of interventions in patients with aortic dissection have also been reported.

Predicting Late Adverse Events in Uncomplicated Type B Dissections

Patients with initially uncomplicated type B aortic dissection have excellent early survival but a 20% to 50% risk of late adverse events.55,56,181 Although early TEVAR may prevent or at least delay late complications, only a subset of high-risk patients are likely to benefit from the procedure, which is not without its own risks.182184 Several studies have sought to identify morphological predictors of aneurysm growth and late adverse events to better risk-stratify these patients.

In a systematic review of 51 original studies, Spinelli and colleagues59 analyzed the consistency of reported morphological predictors of adverse events in patients with uncomplicated type B dissections. Of the wide range of published morphological predictors, only 2 had a consistent effect across the literature: (1) Aortic diameter at presentation was consistently associated with adverse events, and (2) complete false lumen thrombosis always had a protective role. Inconsistent and even conflicting results were reported for other investigated predictors, including false lumen diameter and length; false lumen location (lesser or greater curvature of the aorta); number, size, and location of the primary entry tear; branch vessel involvement; and partial false lumen thrombosis.

The reported inconsistency of morphological features to predict adverse events might be explained by the fact that candidate predictors were analyzed as isolated, unconnected features, not in the context of our evolving understanding of the pathophysiology of aortic dissection in which features are hemodynamically linked. For instance, the effect of the size of the primary entry tear (allowing false lumen inflow) cannot be interpreted meaningfully without knowledge of the false lumen drainage (outflow resistance). Only 1 small study of 83 patients with uncomplicated type B dissection combined 4 independent morphological and 1 clinical predictor into a single prediction model for late adverse events, and 1 of the independent predictors was false lumen drainage (outflow).30 External validation and more comprehensive analyses of aggregated dissection features in larger cohorts are needed. A prerequisite is the development of automated tools to extract the potentially important features because manual segmentation is prohibitively time consuming and unreliable.185

Last, it is important to recognize that some of the morphological predictors such as maximum diameter, the relative proportion of the outer aortic wall circumference encompassing the false lumen, and the occurrence of partial false lumen thrombus change over time. Those changes over time (eg, growth) on serial CT imaging have predictive power of their own.186 Hence, an ideal prediction model for patients with uncomplicated type B dissection not only would predict the risk at baseline (eg, at time of hospital discharge) but also would allow the risk estimate to be updated with new clinical and morphological information at every follow-up encounter. Currently, such models do not exist.

Predicting the Fate of the False Lumen After Surgical or Endovascular Intervention

In experienced hands, surgical repair of the ascending aorta can be safely extended into the aortic arch or beyond with placement of a conventional or “frozen” elephant trunk into the descending thoracic aorta.179,180 Hybrid and endovascular treatment options are also evolving. Ascending repair can be combined with antegrade placement of a descending aortic endograft187 or with a dedicated partially uncovered aortic arch hybrid graft (Ascyrus Medical Dissection Stent) at the time of operation.188 Covered endografts also can be combined with uncovered devices, for example, in the provisional extension to induce complete attachment approach,189 in acute type B aortic dissection.

Although the long-term effect of these interventions will not be known for many years, imaging and simulations can help anticipate early markers of success, notably the induction of false lumen thrombosis. Computer simulations developed at the Imperial College London have shown that the location of thrombus formation can be predicted from patient-specific dissection morphology before and after placement of, for example, an endograft.190,191

New Developments: Machine Learning

The potential of using the massive amounts of accumulated radiological data to predict rupture and to determine the best timing for intervention was recognized many years ago.70 Except for maximum aortic diameter, however, the importance of many candidate morphological features remains uncertain, and manual annotation (segmentation) of imaging features in patients with aortic dissection is difficult and prohibitively time consuming for clinical application.

New machine-learning algorithms may overcome these limitations. Several dissection features such as the true and false lumen and diameter measurements have been successfully identified with deep-learning algorithms.185,192 Aortic landmarks have been detected with a range of techniques, including deep-reinforcement learning.193 Random forest classification methods have been used to investigate the risk of developing type A dissection according to CT and clinical data.194 Aneurysm growth also has been predicted with encouraging accuracy in abdominal aortic aneurysms with a set of benchmark learning techniques.195

Although immensely promising, these initial results from rapidly evolving machine-learning applications for segmentation, classification, and risk prediction in aortic dissection are still a far cry from clinical-grade, robust applications. Validating these new tools with large enough well-curated and expert-annotated imaging databases with clinical outcomes is still required but difficult to accomplish in patients with a relatively rare, anatomically complex chronic disease.

SUMMARY

Chronic aortic dissection is an underrecognized cardiovascular disease and growing health care burden. Imaging and image processing will continue to play a pivotal role in surveillance and clinical decision-making in these patients, as long as accurate and standardized measurements of aortic dimensions over time are provided.

There is a great need for additional research into the epidemiology and natural history, pathophysiology, management, and prediction of outcomes in patients with chronic aortic dissection to support the ongoing paradigm shift from the prevailing watch-and-wait treatment strategy to an individualized selection of traditional or new surgical, endovascular, or hybrid interventions in the future. Important questions identified by the writing group, intended to serve as an impetus for additional research, are listed in the Table. Given the uncommon nature, unspecified economic impact, and long follow-up needed to study chronic aortic dissection, funding for research is challenging, and significant advances will undoubtedly require interdisciplinary collaboration across a large network of research and clinical centers. High-resolution imaging data, combined with computer simulations, biomechanical modeling, and machine learning, may help answer many of the remaining questions and ultimately improve the lives of patients with chronic aortic dissection.

Table.

Critical Knowledge Gaps and Research Needs in Imaging and Surveillance of Chronic Aortic Dissection

Epidemiology and economic impact
 The actual prevalence of patients living with chronic aortic dissection is currently unknown.
 The cumulative lifetime expenses for long-term specialty care and interventions in patients with chronic dissection have not been adequately appraised.
Natural history and pathophysiology
 The natural history and the effect of evolving therapies on outcomes in patients with chronic dissection are incompletely established. Prospective, multicenter registries with concurrent recording of clinical and imaging data are needed.
 Sex-and racial differences in false lumen growth over time and in long-term outcomes and prognosis have not been investigated in patients with chronic dissection, despite known differences in incidence age, clinical presentation, and short-term outcomes in women.
 The hemodynamics and mechanobiology of the dissected aortic wall and their interplay with progression and complications are incompletely understood.
 The biological, cellular, and molecular processes involved in the repair, progression, and remodeling of affected arteries need to be further investigated.
Clinical management
 New tools and methods for modeling treatment effects, eg, how different surgical or endovascular techniques affect blood flow, false lumen pressure, and the chance of false lumen thrombus formation, are needed.
 Adequate data to establish evidence-based standardization and personalization of surveillance intervals are currently lacking.
Imaging techniques and measurements
 Better tools to facilitate the current manual and semiautomated diameter measurements, including comparison measurements and documentation, are urgently needed.
 New machine-learning tools for fully automated or semiautomated extraction of prognostically relevant features beyond diameters are required.
Risk prediction and modeling
 Validated prediction models for risk stratification and guidance of treatment at the time of the acute event are highly desirable. Ideally, patient risk can be updated at each follow-up interval.
 The best combination of morphological, functional, and clinical parameters for predicting adverse events has not yet been determined.
 Projecting geometric changes over time is necessary to foresee potential changes in anatomic suitability for endografting over time.

Supplementary Material

Supplemental Video 1
Download video file (529.3KB, mov)
Supplemental Figures

Supplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/HCI.0000000000000075.

Acknowledgments

This statement was approved by the American Heart Association Science Advisory and Coordinating Committee on September 8, 2021, and the American Heart Association Executive Committee on October 25, 2021. A copy of the document is available at https://professional.heart.org/statements by using either “Search for Guidelines & Statements” or the “Browse by Topic” area. To purchase additional reprints, call 215-356-2721 or email Meredith.Edelman@wolterskluwer.com.

Footnotes

The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.

Disclosures

Writing Group Disclosures
Writing group member Employment Research grant Other research support Speakers’ bureau/honoraria Expert witness Ownership interest Consultant/advisory board Other
Dominik Fleischmann Stanford University School of Medicine None None None None None None None
Michael P. Fischbein Stanford University School of Medicine NIH (R01; not related to review) None None None None None None
Rana O. Afifi McGovern Medical School at The University of Texas Health Science Center at Houston. Affiliated with Memorial Hermann Heart & Vascular Institute None None None None None None None
Ana I. Casanegra Mayo Clinic None None None None None None None
John A. Elefteriades Yale University School of Medicine, Aortic Institute at Yale–New Haven Hospital None None None 2 Cases Cool-Spine* CryoLife*; Terumo/Vascutek* None
Thomas G. Gleason University of Maryland School of Medicine None None None None None Abbott (unpaid)* None
Kate Hanneman Toronto General Hospital, Peter Munk Cardiac Centre, University Health Network, University of Toronto (Canada) None None None None None None None
Eric E. Roselli Cleveland Clinic Heart and Vascular Institute Cook; Cryolife; Gore; Medtronic; TerumoAortic (PI for research grants for all) None Cook*; Gore*; TerumoAortic* None None Cryolife*; Gore*; Medtronic*; TerumoAortic* None
Martin J. Willemink Stanford University School of Medicine None None None None None None None
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
*
Modest.
Significant.
Reviewer Disclosures
Reviewer Employment Research grant Other research support Speakers’ bureau/honoraria Expert witness Ownership interest Consultant/advisory board Other
Nicholas S. Burris University of Michigan Radiologic Society of North America (active research grant to study hemodynamics in type B dissection using 4D flow MRI) None None None None None None
R. Scott McClure Foothills Medical Centre, University of Calgary (Canada) None None None None None None None
Christoph A. Nienaber The Royal Brompton & Harefield NHS Trust (United Kingdom) None None None None None None None
This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
Significant.

The expert peer review of AHA-commissioned documents (eg, scientific statements, clinical practice guidelines, systematic reviews) is conducted by the AHA Office of Science Operations. For more on AHA statements and guidelines development, visit https://professional.heart.org/statements. Select the “Guidelines & Statements” drop-down menu, then click “Publication Development.”

Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American Heart Association. Instructions for obtaining permission are located at https://www.heart.org/permissions. A link to the “Copyright Permissions Request Form” appears in the second paragraph (https://www.heart.org/en/about-us/statements-and-policies/copyright-request-form).

Contributor Information

Dominik Fleischmann, Stanford University School of Medicine.

Rana O. Afifi, McGovern Medical School at The University of Texas Health Science Center at Houston. Affiliated with Memorial Hermann Heart & Vascular Institute.

Ana I. Casanegra, Mayo Clinic.

John A. Elefteriades, Yale University School of Medicine, Aortic Institute at Yale–New Haven Hospital.

Thomas G. Gleason, University of Maryland School of Medicine.

Kate Hanneman, Toronto General Hospital, Peter Munk Cardiac Centre, University Health Network, University of Toronto (Canada).

Eric E. Roselli, Cleveland Clinic Heart and Vascular Institute.

Martin J. Willemink, Stanford University School of Medicine.

Michael P. Fischbein, Stanford University School of Medicine.

REFERENCES

  • 1.Gliatto T, Benet L, Laudadio M, Wang C, Chiu A, Bell C, Fleeman M. John Ritter 1948–2003. People Magazine. 2003:1. Accessed January 4, 2022. https://people.com/premium/john-ritter-1948-2003/ [Google Scholar]
  • 2.Ross JK. The death of King George II, with a biographical note on Dr Frank Nicholls, physician to the King. J Med Biogr. 1999;7:228–233. doi: 10.1177/096777209900700409 [DOI] [PubMed] [Google Scholar]
  • 3.Sabik JF, Lytle BW, Blackstone EH, McCarthy PM, Loop FD, Cosgrove DM. Long-term effectiveness of operations for ascending aortic dissections. J Thorac Cardiovasc Surg. 2000;119:946–962. doi: 10.1016/S0022-5223(00)70090-0 [DOI] [PubMed] [Google Scholar]
  • 4.Olsson C, Ahlsson A, Fuglsang S, Geirsson A, Gunn J, Hansson EC, Hjortdal V, Jarvela K, Jeppsson A, Mennander A, et al. Medium-term survival after surgery for acute type A aortic dissection is improving. Eur J Cardiothorac Surg. 2017;52:852–857. doi: 10.1093/ejcts/ezx302 [DOI] [PubMed] [Google Scholar]
  • 5.Evangelista A, Isselbacher EM, Bossone E, Gleason TG, Eusanio MD, Sechtem U, Ehrlich MP, Trimarchi S, Braverman AC, Myrmel T, et al. ; IRAD Investigators. Insights from the International Registry of Acute Aortic Dissection: a 20-year experience of collaborative clinical research. Circulation. 2018;137:1846–1860. doi: 10.1161/CIRCULATIONAHA.117.031264 [DOI] [PubMed] [Google Scholar]
  • 6.Evangelista A, Rabasa JM, Mosquera VX, Barros A, Fernández-Tarrio R, Calvo-Iglesias F, Ferrera C, Rozado J, López-Ayerbe J, Garrote C, et al. Diagnosis, management and mortality in acute aortic syndrome: results of the Spanish Registry of Acute Aortic Syndrome (RESA-II). Eur Heart J Acute Cardiovasc Care. 2018;7:602–608. doi: 10.1177/2048872616682343 [DOI] [PubMed] [Google Scholar]
  • 7.Inoue Y, Matsuda H, Uchida K, Komiya T, Koyama T, Yoshino H, Ito T, Shiiya N, Saiki Y, Kawaharada N, et al. Analysis of acute type A aortic dissection in Japan Registry of Aortic Dissection (JRAD). Ann Thorac Surg. 2020;110:790–798. doi: 10.1016/j.athoracsur.2019.12.051 [DOI] [PubMed] [Google Scholar]
  • 8.McClure RS, Brogly SB, Lajkosz K, McClintock C, Payne D, Smith HN, Johnson AP. Economic burden and healthcare resource use for thoracic aortic dissections and thoracic aortic aneurysms: a population-based cost-of-illness analysis. J Am Heart Assoc. 2020;9:e014981. doi: 10.1161/JAHA.119.014981 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Morris PD, Narracott A, von Tengg-Kobligk H, Silva Soto DA, Hsiao S, Lungu A, Evans P, Bressloff NW, Lawford PV, Hose DR, et al. Computational fluid dynamics modelling in cardiovascular medicine. Heart. 2016;102:18–28. doi: 10.1136/heartjnl-2015-308044 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Bäumler K, Vedula V, Sailer AM, Seo J, Chiu P, Mistelbauer G, Chan FP, Fischbein MP, Marsden AL, Fleischmann D. Fluid-structure interaction simulations of patient-specific aortic dissection. Biomech Model Mechanobiol. 2020;19:1607–1628. doi: 10.1007/s10237-020-01294-8 [DOI] [PubMed] [Google Scholar]
  • 11.Humphrey JD, Schwartz MA, Tellides G, Milewicz DM. Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections. Circ Res. 2015;116:1448–1461. doi: 10.1161/CIRCRESAHA.114.304936 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Akin I, Nienaber CA. Prediction of aortic dissection. Heart. 2020;106:870–871. doi: 10.1136/heartjnl-2020-316617 [DOI] [PubMed] [Google Scholar]
  • 13.Crawford ES. The diagnosis and management of aortic dissection. JAMA. 1990;264:2537–2541. [PubMed] [Google Scholar]
  • 14.Hirst AE Jr, Johns VJ Jr, Kime SW Jr. Dissecting aneurysm of the aorta: a review of 505 cases. Medicine (Baltimore). 1958;37:217–279. doi: 10.1097/00005792-195809000-00003 [DOI] [PubMed] [Google Scholar]
  • 15.Evangelista A Insights from the International Registry of Acute Aortic Dissection: what have we learned? Eur Cardiol. 2008;4:79–82. doi: 10.15420/ecr.2008.4.1.79 [DOI] [Google Scholar]
  • 16.Steuer J, Björck M, Mayer D, Wanhainen A, Pfammatter T, Lachat M. Distinction between acute and chronic type B aortic dissection: is there a sub-acute phase? Eur J Vasc Endovasc Surg. 2013;45:627–631. doi: 10.1016/j.ejvs.2013.03.013 [DOI] [PubMed] [Google Scholar]
  • 17.Booher AM, Isselbacher EM, Nienaber CA, Trimarchi S, Evangelista A, Montgomery DG, Froehlich JB, Ehrlich MP, Oh JK, Januzzi JL, et al. ; IRAD Investigators. The IRAD classification system for characterizing survival after aortic dissection. Am J Med. 2013;126:730.e19–730.e24. doi: 10.1016/j.amjmed.2013.01.020 [DOI] [PubMed] [Google Scholar]
  • 18.Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, Evangelista A, Fattori R, Suzuki T, Oh JK, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000;283:897–903. doi: 10.1001/jama.283.7.897 [DOI] [PubMed] [Google Scholar]
  • 19.Howard DP, Banerjee A, Fairhead JF, Perkins J, Silver LE, Rothwell PM; Oxford Vascular Study. Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study. Circulation. 2013;127:2031–2037. doi: 10.1161/CIRCULATIONAHA.112.000483 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.McClure RS, Brogly SB, Lajkosz K, Payne D, Hall SF, Johnson AP. Epidemiology and management of thoracic aortic dissections and thoracic aortic aneurysms in Ontario, Canada: a population-based study. J Thorac Cardiovasc Surg. 2018;155:2254–2264.e4. doi: 10.1016/j.jtcvs.2017.11.105 [DOI] [PubMed] [Google Scholar]
  • 21.Wundram M, Falk V, Eulert-Grehn JJ, Herbst H, Thurau J, Leidel BA, Göncz E, Bauer W, Habazettl H, Kurz SD. Incidence of acute type A aortic dissection in emergency departments. Sci Rep. 2020;10:7434. doi: 10.1038/s41598-020-64299-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Pape LA, Awais M, Woznicki EM, Suzuki T, Trimarchi S, Evangelista A, Myrmel T, Larsen M, Harris KM, Greason K, et al. Presentation, diagnosis, and outcomes of acute aortic dissection: 17-year trends from the International Registry of Acute Aortic Dissection. J Am Coll Cardiol. 2015;66:350–358. doi: 10.1016/j.jacc.2015.05.029 [DOI] [PubMed] [Google Scholar]
  • 23.Charilaou P, Ziganshin BA, Peterss S, Rajbanshi BG, Rajakaruna C, Zaza KJ, Salloum MN, Mukherjee A, Tranquilli M, Rizzo JA, et al. Current experience with acute type B aortic dissection: validity of the complication-specific approach in the present era. Ann Thorac Surg. 2016;101:936–943. doi: 10.1016/j.athoracsur.2015.08.074 [DOI] [PubMed] [Google Scholar]
  • 24.Afifi RO, Sandhu HK, Leake SS, Boutrous ML, Kumar V 3rd, Azizzadeh A, Charlton-Ouw KM, Saqib NU, Nguyen TC, Miller CC 3rd, et al. Outcomes of patients with acute type B (DeBakey III) aortic dissection: a 13-year, single-center experience. Circulation. 2015;132:748–754. doi: 10.1161/CIRCULATIONAHA.115.015302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Tan ME, Morshuis WJ, Dossche KM, Kelder JC, Waanders FG, Schepens MA. Long-term results after 27 years of surgical treatment of acute type A aortic dissection. Ann Thorac Surg. 2005;80:523–529. doi: 10.1016/j.athoracsur.2005.02.059 [DOI] [PubMed] [Google Scholar]
  • 26.Tsai TT, Fattori R, Trimarchi S, Isselbacher E, Myrmel T, Evangelista A, Hutchison S, Sechtem U, Cooper JV, Smith DE, et al. ; International Registry of Acute Aortic Dissection. Long-term survival in patients presenting with type B acute aortic dissection: insights from the International Registry of Acute Aortic Dissection. Circulation. 2006;114:2226–2231. doi: 10.1161/CIRCULATIONAHA.106.622340 [DOI] [PubMed] [Google Scholar]
  • 27.Halstead JC, Meier M, Etz C, Spielvogel D, Bodian C, Wurm M, Shahani R, Griepp RB. The fate of the distal aorta after repair of acute type A aortic dissection. J Thorac Cardiovasc Surg. 2007;133:127–135. doi: 10.1016/j.jtcvs.2006.07.043 [DOI] [PubMed] [Google Scholar]
  • 28.Olsson C, Eriksson N, Ståhle E, Thelin S. Surgical and long-term mortality in 2634 consecutive patients operated on the proximal thoracic aorta. Eur J Cardiothorac Surg. 2007;31:963–969. doi: 10.1016/j.ejcts.2007.01.034 [DOI] [PubMed] [Google Scholar]
  • 29.Lodewyks CL, Prior HJ, Hiebert BM, Nickel NC, Yamashita MH, Ouzounian M, Kumar KK, Arora RC, Tangri N. A province-wide analysis of the epidemiology of thoracic aortic disease: incidence is increasing in a sex-specific way. Can J Cardiol. 2020;36:1729–1738. doi: 10.1016/j.cjca.2019.11.013 [DOI] [PubMed] [Google Scholar]
  • 30.Sailer AM, van Kuijk SM, Nelemans PJ, Chin AS, Kino A, Huininga M, Schmidt J, Mistelbauer G, Bäumler K, Chiu P, et al. Computed tomography imaging features in acute uncomplicated Stanford type-b aortic dissection predict late adverse events. Circ Cardiovasc Imaging. 2017;10:e005709. doi: 10.1161/CIRCIMAGING.116.005709 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kohl LP, Isselbacher EM, Majahalme N, Evangelista A, Russo MJ, Hutchison S, Bossone E, Suzuki T, Pyeritz RE, Gleason TG, et al. Comparison of outcomes in DeBakey type AI versus AII aortic dissection. Am J Cardiol. 2018;122:689–695. doi: 10.1016/j.amjcard.2018.04.042 [DOI] [PubMed] [Google Scholar]
  • 32.Knipp BS, Deeb GM, Prager RL, Williams CY, Upchurch GR Jr, Patel HJ. A contemporary analysis of outcomes for operative repair of type A aortic dissection in the United States. Surgery. 2007;142:524–528. doi: 10.1016/j.surg.2007.07.012 [DOI] [PubMed] [Google Scholar]
  • 33.Wang Z, Greason KL, Pochettino A, Schaff HV, Suri RM, Stulak JM, Dearani JA. Long-term outcomes of survival and freedom from reoperation on the aortic root or valve after surgery for acute ascending aorta dissection. J Thorac Cardiovasc Surg. 2014;148:2117–2122. doi: 10.1016/j.jtcvs.2013.12.059 [DOI] [PubMed] [Google Scholar]
  • 34.Rylski B, Bavaria JE, Milewski RK, Vallabhajosyula P, Moser W, Kremens E, Pochettino A, Szeto WY, Desai ND. Long-term results of neomedia sinus valsalva repair in 489 patients with type A aortic dissection. Ann Thorac Surg. 2014;98:582–588. doi: 10.1016/j.athoracsur.2014.04.050 [DOI] [PubMed] [Google Scholar]
  • 35.Chiu P, Trojan J, Tsou S, Goldstone AB, Woo YJ, Fischbein MP. Limited root repair in acute type A aortic dissection is safe but results in increased risk of reoperation. J Thorac Cardiovasc Surg. 2018;155:1–7.e1. doi: 10.1016/j.jtcvs.2017.08.137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Tsai TT, Trimarchi S, Nienaber CA. Acute aortic dissection: perspectives from the International Registry of Acute Aortic Dissection (IRAD). Eur J Vasc Endovasc Surg. 2009;37:149–159. doi: 10.1016/j.ejvs.2008.11.032 [DOI] [PubMed] [Google Scholar]
  • 37.Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, et al. ; ESC Committee for Practice Guidelines. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult: the Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2873–2926. doi: 10.1093/eurheartj/ehu281 [DOI] [PubMed] [Google Scholar]
  • 38.Blitzer DN, Vallabhaneni R. IP081: national trends for operative management of uncomplicated type B aortic dissection. J Vasc Surg. 2018;67:e110. doi: 10.1016/j.jvs.2018.03.130 [DOI] [Google Scholar]
  • 39.Wang GJ, Jackson BM, Foley PJ, Damrauer SM, Goodney PP, Kelz RR, Wirtalla C, Fairman RM. National trends in admissions, repair, and mortality for thoracic aortic aneurysm and type B dissection in the National Inpatient Sample. J Vasc Surg. 2018;67:1649–1658. doi: 10.1016/j.jvs.2017.09.050 [DOI] [PubMed] [Google Scholar]
  • 40.Yuan X, Mitsis A, Tang Y, Nienaber CA. The IRAD and beyond: what have we unravelled so far? Gen Thorac Cardiovasc Surg. 2019;67:146–153. doi: 10.1007/s11748-017-0817-6 [DOI] [PubMed] [Google Scholar]
  • 41.Kang WC, Greenberg RK, Mastracci TM, Eagleton MJ, Hernandez AV, Pujara AC, Roselli EE. Endovascular repair of complicated chronic distal aortic dissections: intermediate outcomes and complications. J Thorac Cardiovasc Surg. 2011;142:1074–1083. doi: 10.1016/j.jtcvs.2011.03.008 [DOI] [PubMed] [Google Scholar]
  • 42.Moral S, Cuéllar H, Avegliano G, Ballesteros E, Salcedo MT, Ferreira-González I, García-Dorado D, Evangelista A. Clinical implications of focal intimal disruption in patients with type B intramural hematoma. J Am Coll Cardiol. 2017;69:28–39. doi: 10.1016/j.jacc.2016.10.045 [DOI] [PubMed] [Google Scholar]
  • 43.Svensson LG. Limited intimal aorta tears: royalty torn asunder, and a nation was created. J Am Coll Cardiol. 2018;71:2786–2789. doi: 10.1016/j.jacc.2018.03.530 [DOI] [PubMed] [Google Scholar]
  • 44.Chin AS, Willemink MJ, Kino A, Hinostroza V, Sailer AM, Fischbein MP, Mitchell RS, Berry GJ, Miller DC, Fleischmann D. Acute limited intimal tears of the thoracic aorta. J Am Coll Cardiol. 2018;71:2773–2785. doi: 10.1016/j.jacc.2018.03.531 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Sailer AM, Nelemans PJ, Hastie TJ, Chin AS, Huininga M, Chiu P, Fischbein MP, Dake MD, Miller DC, Schurink GW, et al. Prognostic significance of early aortic remodeling in acute uncomplicated type B aortic dissection and intramural hematoma. J Thorac Cardiovasc Surg. 2017;154:1192–1200. doi: 10.1016/j.jtcvs.2017.04.064 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Coady MA, Rizzo JA, Hammond GL, Mandapati D, Darr U, Kopf GS, Elefteriades JA. What is the appropriate size criterion for resection of thoracic aortic aneurysms? J Thorac Cardiovasc Surg. 1997;113:476–491. doi: 10.1016/S0022-5223(97)70360-X [DOI] [PubMed] [Google Scholar]
  • 47.Jonker FH, Trimarchi S, Rampoldi V, Patel HJ, O’Gara P, Peterson MD, Fattori R, Moll FL, Voehringer M, Pyeritz RE, et al. ; International Registry of Acute Aortic Dissection (IRAD) Investigators. Aortic expansion after acute type B aortic dissection. Ann Thorac Surg. 2012;94:1223–1229. doi: 10.1016/j.athoracsur.2012.05.040 [DOI] [PubMed] [Google Scholar]
  • 48.Tolenaar JL, van Keulen JW, Jonker FH, van Herwaarden JA, Verhagen HJ, Moll FL, Muhs BE, Trimarchi S. Morphologic predictors of aortic dilatation in type B aortic dissection. J Vasc Surg. 2013;58:1220–1225. doi: 10.1016/j.jvs.2013.05.031 [DOI] [PubMed] [Google Scholar]
  • 49.Trimarchi S, Tolenaar JL, Jonker FH, Murray B, Tsai TT, Eagle KA, Rampoldi V, Verhagen HJ, van Herwaarden JA, Moll FL, et al. Importance of false lumen thrombosis in type B aortic dissection prognosis. J Thorac Cardiovasc Surg. 2013;145(suppl):S208–S212. doi: 10.1016/j.jtcvs.2012.11.048 [DOI] [PubMed] [Google Scholar]
  • 50.Sueyoshi E, Sakamoto I, Uetani M. Growth rate of affected aorta in patients with type B partially closed aortic dissection. Ann Thorac Surg. 2009;88:1251–1257. doi: 10.1016/j.athoracsur.2009.06.023 [DOI] [PubMed] [Google Scholar]
  • 51.Peterss S, Mansour AM, Ross JA, Vaitkeviciute I, Charilaou P, Dumfarth J, Fang H, Ziganshin BA, Rizzo JA, Adeniran AJ, et al. Changing pathology of the thoracic aorta from acute to chronic dissection: literature review and insights. J Am Coll Cardiol. 2016;68:1054–1065. doi: 10.1016/j.jacc.2016.05.091 [DOI] [PubMed] [Google Scholar]
  • 52.Charlton-Ouw KM, Sandhu HK, Leake SS, Miller CC 3rd, Afifi RO, Azizzadeh A, Estrera AL, Safi HJ. New type A dissection after acute type B aortic dissection. J Vasc Surg. 2018;67:85–92. doi: 10.1016/j.jvs.2017.05.121 [DOI] [PubMed] [Google Scholar]
  • 53.Isselbacher EM, Bonaca MP, Di Eusanio M, Froehlich J, Bossone E, Sechtem U, Pyeritz R, Patel H, Khoynezhad A, Eckstein HH, et al. ; International Registry of Aortic Dissection (IRAD) Investigators. Recurrent aortic dissection: observations from the International Registry of Aortic Dissection. Circulation. 2016;134:1013–1024. doi: 10.1161/CIRCULATIONAHA.115.019359 [DOI] [PubMed] [Google Scholar]
  • 54.Fattori R, Bacchi-Reggiani L, Bertaccini P, Napoli G, Fusco F, Longo M, Pierangeli A, Gavelli G. Evolution of aortic dissection after surgical repair. Am J Cardiol. 2000;86:868–872. doi: 10.1016/s0002-9149(00)01108-5 [DOI] [PubMed] [Google Scholar]
  • 55.Durham CA, Cambria RP, Wang LJ, Ergul EA, Aranson NJ, Patel VI, Conrad MF. The natural history of medically managed acute type B aortic dissection. J Vasc Surg. 2015;61:1192–1198. doi: 10.1016/j.jvs.2014.12.038 [DOI] [PubMed] [Google Scholar]
  • 56.Juvonen T, Ergin MA, Galla JD, Lansman SL, McCullough JN, Nguyen K, Bodian CA, Ehrlich MP, Spielvogel D, Klein JJ, et al. Risk factors for rupture of chronic type B dissections. J Thorac Cardiovasc Surg. 1999;117:776–786. doi: 10.1016/S0022-5223(99)70299-0 [DOI] [PubMed] [Google Scholar]
  • 57.Zierer A, Voeller RK, Hill KE, Kouchoukos NT, Damiano RJ Jr, Moon MR. Aortic enlargement and late reoperation after repair of acute type A aortic dissection. Ann Thorac Surg. 2007;84:479–486. doi: 10.1016/j.athoracsur.2007.03.084 [DOI] [PubMed] [Google Scholar]
  • 58.Tadros RO, Tang GHL, Barnes HJ, Mousavi I, Kovacic JC, Faries P, Olin JW, Marin ML, Adams DH. Optimal treatment of uncomplicated type B aortic dissection: JACC review topic of the week. J Am Coll Cardiol. 2019;74:1494–1504. doi: 10.1016/j.jacc.2019.07.063 [DOI] [PubMed] [Google Scholar]
  • 59.Spinelli D, Benedetto F, Donato R, Piffaretti G, Marrocco-Trischitta MM, Patel HJ, Eagle KA, Trimarchi S. Current evidence in predictors of aortic growth and events in acute type B aortic dissection. J Vasc Surg. 2018;68:1925–1935.e8. doi: 10.1016/j.jvs.2018.05.232 [DOI] [PubMed] [Google Scholar]
  • 60.Zhao S, Gu H, Chen B, Cheng Z, Yang S, Duan Y, Ghavamian A, Wang X. Dynamic imaging features of retrospective cardiac gating CT angiography influence delayed adverse events in acute uncomplicated type B aortic dissections. Cardiovasc Intervent Radiol. 2020;43:620–629. doi: 10.1007/s00270-019-02395-3 [DOI] [PubMed] [Google Scholar]
  • 61.Burris NS, Patel HJ, Hope MD. Retrograde flow in the false lumen: marker of a false lumen under stress? J Thorac Cardiovasc Surg. 2019;157:488–491. doi: 10.1016/j.jtcvs.2018.06.092 [DOI] [PubMed] [Google Scholar]
  • 62.Karmonik C, Partovi S, Müller-Eschner M, Bismuth J, Davies MG, Shah DJ, Loebe M, Böckler D, Lumsden AB, von Tengg-Kobligk H. Longitudinal computational fluid dynamics study of aneurysmal dilatation in a chronic DeBakey type III aortic dissection. J Vasc Surg. 2012;56:260–263.e1. doi: 10.1016/j.jvs.2012.02.064 [DOI] [PubMed] [Google Scholar]
  • 63.Chen HY, Peelukhana SV, Berwick ZC, Kratzberg J, Krieger JF, Roeder B, Chambers S, Kassab GS. Editor’s choice: fluid-structure interaction simulations of aortic dissection with bench validation. Eur J Vasc Endovasc Surg. 2016;52:589–595. doi: 10.1016/j.ejvs.2016.07.006 [DOI] [PubMed] [Google Scholar]
  • 64.Chung JW, Elkins C, Sakai T, Kato N, Vestring T, Semba CP, Slonim SM, Dake MD. True-lumen collapse in aortic dissection, part I: evaluation of causative factors in phantoms with pulsatile flow. Radiology. 2000;214:87–98. doi: 10.1148/radiology.214.1.r00ja3287 [DOI] [PubMed] [Google Scholar]
  • 65.Rudenick PA, Bijnens BH, García-Dorado D, Evangelista A. An in vitro phantom study on the influence of tear size and configuration on the hemodynamics of the lumina in chronic type B aortic dissections. J Vasc Surg. 2013;57:464–474.e5. doi: 10.1016/j.jvs.2012.07.008 [DOI] [PubMed] [Google Scholar]
  • 66.Tong J, Cheng Y, Holzapfel GA. Mechanical assessment of arterial dissection in health and disease: advancements and challenges. J Biomech. 2016;49:2366–2373. doi: 10.1016/j.jbiomech.2016.02.009 [DOI] [PubMed] [Google Scholar]
  • 67.Sommer G, Sherifova S, Oberwalder PJ, Dapunt OE, Ursomanno PA, DeAnda A, Griffith BE, Holzapfel GA. Mechanical strength of aneurysmatic and dissected human thoracic aortas at different shear loading modes. J Biomech. 2016;49:2374–2382. doi: 10.1016/j.jbiomech.2016.02.042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Rolf-Pissarczyka M, Li K, Fleischmann D, Holzapfel GA. A discrete approach for modeling degraded elastic fibers in aortic dissection. Comput Methods Appl Mech Eng. 2021;373:113511. doi: 10.1016/j.cma.2020.113511 [DOI] [Google Scholar]
  • 69.Dillon-Murphy D, Noorani A, Nordsletten D, Figueroa CA. Multi-modality image-based computational analysis of haemodynamics in aortic dissection. Biomech Model Mechanobiol. 2016;15:857–876. doi: 10.1007/s10237-015-0729-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, et al. ; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American College of Radiology; American Stroke Association; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society of Thoracic Surgeons; Society for Vascular Medicine. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine [published correction appears in Circulation. 2010;122:e410]. Circulation. 2010;121:e266–e369. Doi: 10.1161/cir.0b013e3181d4739e [DOI] [PubMed] [Google Scholar]
  • 71.Wheat MW Jr, Palmer RF, Bartley TD, Seelman RC. Treatment of dissecting aneurysms of the aorta without surgery. J Thorac Cardiovasc Surg. 1965;50:364–373. [PubMed] [Google Scholar]
  • 72.Feldman M, Shah M, Elefteriades JA. Medical management of acute type A aortic dissection. Ann Thorac Cardiovasc Surg. 2009;15:286–293. [PubMed] [Google Scholar]
  • 73.Riambau V, Böckler D, Brunkwall J, Cao P, Chiesa R, Coppi G, Czerny M, Fraedrich G, Haulon S, Jacobs MJ, et al. Editor’s choice: management of descending thoracic aorta diseases: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2017;53:4–52. doi: 10.1016/j.ejvs.2016.06.005 [DOI] [PubMed] [Google Scholar]
  • 74.Grabenwöger M, Alfonso F, Bachet J, Bonser R, Czerny M, Eggebrecht H, Evangelista A, Fattori R, Jakob H, Lönn L, et al. ; European Association for Cardio-Thoracic Surgery (EACTS); European Society of Cardiology (ESC); European Association of Percutaneous Cardiovascular Interventions (EAPCI). Thoracic endovascular aortic repair (TEVAR) for the treatment of aortic diseases: a position statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg. 2012;42:17–24. doi: 10.1093/ejcts/ezs107 [DOI] [PubMed] [Google Scholar]
  • 75.Lombardi JV, Hughes GC, Appoo JJ, Bavaria JE, Beck AW, Cambria RP, Charlton-Ouw K, Eslami MH, Kim KM, Leshnower BG, et al. Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) reporting standards for type B aortic dissections. Ann Thorac Surg. 2020;109:959–981. doi: 10.1016/j.athoracsur.2019.10.005 [DOI] [PubMed] [Google Scholar]
  • 76.Zierler RE, Jordan WD, Lal BK, Mussa F, Leers S, Fulton J, Pevec W, Hill A, Murad MH. The Society for Vascular Surgery practice guidelines on followup after vascular surgery arterial procedures. J Vasc Surg. 2018;68:256–284. doi: 10.1016/j.jvs.2018.04.018 [DOI] [PubMed] [Google Scholar]
  • 77.Elefteriades JA, Lovoulos CJ, Coady MA, Tellides G, Kopf GS, Rizzo JA. Management of descending aortic dissection. Ann Thorac Surg. 1999;67:2002–2005. doi: 10.1016/s0003-4975(99)00428-2 [DOI] [PubMed] [Google Scholar]
  • 78.Coselli JS, LeMaire SA. Current status of thoracoabdominal aortic aneurysm repair in Marfan syndrome. J Card Surg. 1997;12:167–172. [PubMed] [Google Scholar]
  • 79.LeMaire SA, Carter SA, Volguina IV, Laux AT, Milewicz DM, Borsato GW, Cheung CK, Bozinovski J, Markesino JM, Vaughn WK, et al. Spectrum of aortic operations in 300 patients with confirmed or suspected Marfan syndrome. Ann Thorac Surg. 2006;81:2063–2078. doi: 10.1016/j.athoracsur.2006.01.070 [DOI] [PubMed] [Google Scholar]
  • 80.Griepp RB, Ergin MA, Galla JD, Lansman SL, McCullough JN, Nguyen KH, Klein JJ, Spielvogel D. Natural history of descending thoracic and thoracoabdominal aneurysms. Ann Thorac Surg. 1999;67:1927–1930. doi: 10.1016/s0003-4975(99)00427-0 [DOI] [PubMed] [Google Scholar]
  • 81.Coselli JS, LeMaire SA, Preventza O, de la Cruz KI, Cooley DA, Price MD, Stolz AP, Green SY, Arredondo CN, Rosengart TK. Outcomes of 3309 thoracoabdominal aortic aneurysm repairs. J Thorac Cardiovasc Surg. 2016;151:1323–1337. doi: 10.1016/j.jtcvs.2015.12.050 [DOI] [PubMed] [Google Scholar]
  • 82.Boufi M, Patterson BO, Loundou AD, Boyer L, Grima MJ, Loftus IM, Holt PJ. Endovascular versus open repair for chronic type B dissection treatment: a meta-analysis. Ann Thorac Surg. 2019;107:1559–1570. doi: 10.1016/j.athoracsur.2018.10.045 [DOI] [PubMed] [Google Scholar]
  • 83.Corvera J, Copeland H, Blitzer D, Hicks A, Manghelli J, Hess P, Fehrenbacher J. Open repair of chronic thoracic and thoracoabdominal aortic dissection using deep hypothermia and circulatory arrest. J Thorac Cardiovasc Surg. 2017;154:389–395. doi: 10.1016/j.jtcvs.2017.03.020 [DOI] [PubMed] [Google Scholar]
  • 84.Conrad MF, Chung TK, Cambria MR, Paruchuri V, Brady TJ, Cambria RP. Effect of chronic dissection on early and late outcomes after descending thoracic and thoracoabdominal aneurysm repair. J Vasc Surg. 2011;53:600–607. doi: 10.1016/j.jvs.2010.09.053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Conway AM, Sadek M, Lugo J, Pillai JB, Pellet Y, Panagopoulos G, Carroccio A, Plestis K. Outcomes of open surgical repair for chronic type B aortic dissections. J Vasc Surg. 2014;59:1217–1223. doi: 10.1016/j.jvs.2013.11.002 [DOI] [PubMed] [Google Scholar]
  • 86.Estrera AL, Jan A, Sandhu H, Shalhub S, Medina-Castro M, Nguyen TC, Azizzadeh A, Charlton-Ouw K, Miller CC, Safi HJ. Outcomes of open repair for chronic descending thoracic aortic dissection. Ann Thorac Surg. 2015;99:786–793. doi: 10.1016/j.athoracsur.2014.08.077 [DOI] [PubMed] [Google Scholar]
  • 87.Fujikawa T, Yamamoto S, Sekine Y, Oshima S, Kasai R, Mochida Y, Ozaki K, Sasaguri S. Operative results and clinical features of chronic Stanford type B aortic dissection: examination of 234 patients over 6 years. Eur J Vasc Endovasc Surg. 2015;50:738–743. doi: 10.1016/j.ejvs.2015.07.012 [DOI] [PubMed] [Google Scholar]
  • 88.Pujara AC, Roselli EE, Hernandez AV, Vargas Abello LM, Burke JM, Svensson LG, Greenberg RK. Open repair of chronic distal aortic dissection in the endovascular era: implications for disease management. J Thorac Cardiovasc Surg. 2012;144:866–873. doi: 10.1016/j.jtcvs.2012.01.021 [DOI] [PubMed] [Google Scholar]
  • 89.Zoli S, Etz CD, Roder F, Mueller CS, Brenner RM, Bodian CA, Di Luozzo G, Griepp RB. Long-term survival after open repair of chronic distal aortic dissection. Ann Thorac Surg. 2010;89:1458–1466. doi: 10.1016/j.athoracsur.2010.02.014 [DOI] [PubMed] [Google Scholar]
  • 90.Kouchoukos NT, Kulik A, Castner CF. Open thoracoabdominal aortic repair for chronic type B dissection. J Thorac Cardiovasc Surg. 2015;149(suppl):S125–S129. doi: 10.1016/j.jtcvs.2014.07.064 [DOI] [PubMed] [Google Scholar]
  • 91.Tanaka A, Sandhu HK, Afifi RO, Miller CC 3rd, Ray A, Hassan M, Safi HJ, Estrera AL. Outcomes of open repairs of chronic distal aortic dissection anatomically amenable to endovascular repairs [published online October 1, 2019]. J Thorac Cardiovasc Surg. doi: 10.1016/j.jtcvs.2019.09.083. https://linking-hub.elsevier.com/retrieve/pii/S0022-5223(19)32094-X [DOI] [PubMed] [Google Scholar]
  • 92.Nienaber CA, Kische S, Rousseau H, Eggebrecht H, Rehders TC, Kundt G, Glass A, Scheinert D, Czerny M, Kleinfeldt T, et al. ; INSTEAD-XL Trial. Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv. 2013;6:407–416. doi: 10.1161/CIRCINTERVENTIONS.113.000463 [DOI] [PubMed] [Google Scholar]
  • 93.Jia X, Guo W, Li TX, Guan S, Yang RM, Liu XP, Zhang MH, Xiong J. The results of stent graft versus medication therapy for chronic type B dissection. J Vasc Surg. 2013;57:406–414. doi: 10.1016/j.jvs.2012.08.064 [DOI] [PubMed] [Google Scholar]
  • 94.Scali ST, Feezor RJ, Chang CK, Stone DH, Hess PJ, Martin TD, Huber TS, Beck AW. Efficacy of thoracic endovascular stent repair for chronic type B aortic dissection with aneurysmal degeneration. J Vasc Surg. 2013;58:10–17.e1. doi: 10.1016/j.jvs.2012.12.071 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Parsa CJ, Williams JB, Bhattacharya SD, Wolfe WG, Daneshmand MA, McCann RL, Hughes GC. Midterm results with thoracic endovascular aortic repair for chronic type B aortic dissection with associated aneurysm. J Thorac Cardiovasc Surg. 2011;141:322–327. doi: 10.1016/j.jtcvs.2010.10.043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Andacheh ID, Donayre C, Othman F, Walot I, Kopchok G, White R. Patient outcomes and thoracic aortic volume and morphologic changes following thoracic endovascular aortic repair in patients with complicated chronic type B aortic dissection. J Vasc Surg. 2012;56:644–650. doi: 10.1016/j.jvs.2012.02.050 [DOI] [PubMed] [Google Scholar]
  • 97.Mani K, Clough RE, Lyons OT, Bell RE, Carrell TW, Zayed HA, Waltham M, Taylor PR. Predictors of outcome after endovascular repair for chronic type B dissection. Eur J Vasc Endovasc Surg. 2012;43:386–391. doi: 10.1016/j.ejvs.2012.01.016 [DOI] [PubMed] [Google Scholar]
  • 98.Fattouch K, Sampognaro R, Navarra E, Caruso M, Pisano C, Coppola G, Speziale G, Ruvolo G. Long-term results after repair of type A acute aortic dissection according to false lumen patency. Ann Thorac Surg. 2009;88:1244–1250. doi: 10.1016/j.athoracsur.2009.06.055 [DOI] [PubMed] [Google Scholar]
  • 99.Arafat A, Roselli EE, Idrees JJ, Feng K, Banaszak L, Eagleton M, Menon V, Svensson LG. Stent grafting acute aortic dissection: comparison of DeBakey extent IIIA versus IIIB. Ann Thorac Surg. 2016;102:1473–1481. doi: 10.1016/j.athoracsur.2016.04.085 [DOI] [PubMed] [Google Scholar]
  • 100.Kitamura T, Torii S, Oka N, Horai T, Nakashima K, Itatani K, Koyama S, Hari Y, Araki H, Sato H, et al. Key success factors for thoracic endovascular aortic repair for non-acute Stanford type B aortic dissection. Eur J Cardiothorac Surg. 2014;46:432–437. doi: 10.1093/ejcts/ezu012 [DOI] [PubMed] [Google Scholar]
  • 101.Lombardi JV, Cambria RP, Nienaber CA, Chiesa R, Teebken O, Lee A, Mossop P, Bharadwaj P; STABLE Investigators. Prospective multicenter clinical trial (STABLE) on the endovascular treatment of complicated type B aortic dissection using a composite device design. J Vasc Surg. 2012;55:629–640.e2. doi: 10.1016/j.jvs.2011.10.022 [DOI] [PubMed] [Google Scholar]
  • 102.Faure EM, El Batti S, Sutter W, Bel A, Julia P, Achouh P, Alsac JM. Stent-assisted balloon dilatation of chronic aortic dissection. J Thorac Cardiovasc Surg. 2021;162:1467–1473. doi: 10.1016/j.jtcvs.2020.01.081 [DOI] [PubMed] [Google Scholar]
  • 103.Kölbel T, Carpenter SW, Lohrenz C, Tsilimparis N, Larena-Avellaneda A, Debus ES. Addressing persistent false lumen flow in chronic aortic dissection: the Knickerbocker technique. J Endovasc Ther. 2014;21:117–122. doi: 10.1583/13-4463MR-R.1 [DOI] [PubMed] [Google Scholar]
  • 104.Miletic KG, Kindzelski BA, Hodges KE, Beach J, Tong MZ, Bakaeen F, Johnston DR, Desai M, Lyden S, Roselli EE. Impact of endovascular false lumen embolization on thoracic aortic remodeling in chronic dissection. Ann Thorac Surg. 2021;111:495–501. doi: 10.1016/j.athoracsur.2020.04.093 [DOI] [PubMed] [Google Scholar]
  • 105.Eleshra A, Kölbel T, Tsilimparis N, Panuccio G, Scheerbaum M, Debus ES, Mogensen J, Rohlffs F. Candy-Plug generation II for false lumen occlusion in chronic aortic dissection: feasibility and early results. J Endovasc Ther. 2019;26:782–786. doi: 10.1177/1526602819871613 [DOI] [PubMed] [Google Scholar]
  • 106.Spanos K, Kölbel T, Rohlffs F, Heidemann F, Giannoukas AD, Debus SE, Tsilimparis N. Intentional targeted false lumen occlusion after aortic dissection: a systematic review of the literature. Ann Vasc Surg. 2019;56:317–329. doi: 10.1016/j.avsg.2018.08.086 [DOI] [PubMed] [Google Scholar]
  • 107.Kitagawa A, Greenberg RK, Eagleton MJ, Mastracci TM, Roselli EE. Fenestrated and branched endovascular aortic repair for chronic type B aortic dissection with thoracoabdominal aneurysms. J Vasc Surg. 2013;58:625–634. doi: 10.1016/j.jvs.2013.01.049 [DOI] [PubMed] [Google Scholar]
  • 108.Tenorio ER, Oderich GS, Farber MA, Schneider DB, Timaran CH, Schanzer A, Beck AW, Motta F, Sweet MP; US Fenestrated and Branched Aortic Research Consortium Investigators. Outcomes of endovascular repair of chronic postdissection compared with degenerative thoracoabdominal aortic aneurysms using fenestrated-branched stent grafts. J Vasc Surg. 2020;72:822–836.e9. doi: 10.1016/j.jvs.2019.10.091 [DOI] [PubMed] [Google Scholar]
  • 109.Werlin EC, Kaushik S, Gasper WJ, Hoffman M, Reilly LM, Chuter TA, Hiramoto JS. Multibranched endovascular aortic aneurysm repair in patients with and without chronic aortic dissections. J Vasc Surg. 2019;70:1419–1426. doi: 10.1016/j.jvs.2019.02.048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Levack MM, Kindzelski BA, Miletic KG, Vargo PR, Bakaeen FG, Johnston DR, Rajeswaran J, Blackstone EH, Roselli EE. Adjunctive endovascular balloon fracture fenestration for chronic aortic dissection [published online October 7, 2020]. J Thorac Cardiovasc Surg. doi: 10.1016/j.jtcvs.2020.09.106. https://linkinghub.elsevier.com/retrieve/pii/S0022-5223(20)32711-2 [DOI] [PubMed] [Google Scholar]
  • 111.Fukuhara S, Tchouta L, Pampati R, Liesman DR, Khaja MS. Laser aortic septotomy during thoracic endovascular aortic repair for chronic type B aortic dissection[published online September 1, 2020]. J Thorac Cardiovasc Surg. doi: 10.1016/j.jtcvs.2020.08.084. https://linkinghub.elsevier.com/retrieve/pii/S0022-5223(20)32475-2 [DOI] [PubMed] [Google Scholar]
  • 112.de Beaufort HWL, Trimarchi S, Korach A, Di Eusanio M, Gilon D, Montgomery DG, Evangelista A, Braverman AC, Chen EP, Isselbacher EM, et al. Aortic dissection in patients with Marfan syndrome based on the IRAD data. Ann Cardiothorac Surg. 2017;6:633–641. doi: 10.21037/acs.2017.10.03 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Shalhub S, Roman MJ, Eagle KA, LeMaire SA, Zhang Q, Evangelista A, Milewicz DM; Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) Consortium. Type B aortic dissection in young individuals with confirmed and presumed heritable thoracic aortic disease. Ann Thorac Surg. 2020;109:534–540. doi: 10.1016/j.athoracsur.2019.07.004 [DOI] [PubMed] [Google Scholar]
  • 114.Giles KA, Beck AW, Lala S, Patterson S, Back M, Fatima J, Arnaoutakis DJ, Arnaoutakis GJ, Beaver TM, Berceli SA, et al. Implications of secondary aortic intervention after thoracic endovascular aortic repair for acute and chronic type B dissection. J Vasc Surg. 2019;69:1367–1378. doi: 10.1016/j.jvs.2018.07.080 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Shalhub S, Byers PH, Hicks KL, Charlton-Ouw K, Zarkowsky D, Coleman DM, Davis FM, Regalado ES, De Caridi G, Weaver KN, et al. A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome. J Vasc Surg. 2019;70:1543–1554. doi: 10.1016/j.jvs.2019.01.069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Brooke BS, Arnaoutakis G, McDonnell NB, Black JH 3rd. Contemporary management of vascular complications associated with Ehlers-Danlos syndrome. J Vasc Surg. 2010;51:131–138. doi: 10.1016/j.jvs.2009.08.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Oderich GS, Panneton JM, Bower TC, Lindor NM, Cherry KJ, Noel AA, Kalra M, Sullivan T, Gloviczki P. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg. 2005;42:98–106. doi: 10.1016/j.jvs.2005.03.053 [DOI] [PubMed] [Google Scholar]
  • 118.Kicska GA, Hurwitz Koweek LM, Ghoshhajra BB, Beache GM, Brown RKJ, Davis AM, Hsu JY, Khosa F, Kligerman SJ, Litmanovich D, et al. ACR appropriateness criteria® suspected acute aortic syndrome. J Am Coll Radiol. 2021;18:S474–S481. doi: 10.1016/j.jacr.2021.09.004 [DOI] [PubMed] [Google Scholar]
  • 119.Patterson BO, Vidal-Diez A, Karthikesalingam A, Holt PJ, Loftus IM, Thompson MM. Comparison of aortic diameter and area after endovascular treatment of aortic dissection. Ann Thorac Surg. 2015;99:95–102. doi: 10.1016/j.athoracsur.2014.08.022 [DOI] [PubMed] [Google Scholar]
  • 120.Blount KJ, Hagspiel KD. Aortic diameter, true lumen, and false lumen growth rates in chronic type B aortic dissection. AJR Am J Roentgenol. 2009;192:W222–W229. doi: 10.2214/AJR.07.3986 [DOI] [PubMed] [Google Scholar]
  • 121.Roos JE, Willmann JK, Weishaupt D, Lachat M, Marincek B, Hilfiker PR. Thoracic aorta: motion artifact reduction with retrospective and prospective electrocardiography-assisted multi-detector row CT. Radiology. 2002;222:271–277. doi: 10.1148/radiol.2221010481 [DOI] [PubMed] [Google Scholar]
  • 122.Nyheim T, Staxrud LE, Jørgensen JJ, Jensen K, Olerud HM, Sandbæk G. Radiation exposure in patients treated with endovascular aneurysm repair: what is the risk of cancer, and can we justify treating younger patients? Acta Radiol. 2017;58:323–330. doi: 10.1177/0284185116651002 [DOI] [PubMed] [Google Scholar]
  • 123.Kalender G, Lisy M, Stock UA, Endisch A, Kornberger A. Identification of factors influencing cumulative long-term radiation exposure in patients undergoing EVAR. Int J Vasc Med. 2017;2017:9763075. doi: 10.1155/2017/9763075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Motaganahalli R, Martin A, Feliciano B, Murphy MP, Slaven J, Dalsing MC. Estimating the risk of solid organ malignancy in patients undergoing routine computed tomography scans after endovascular aneurysm repair. J Vasc Surg. 2012;56:929–937. doi: 10.1016/j.jvs.2012.02.061 [DOI] [PubMed] [Google Scholar]
  • 125.National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. National Academies Press; 2006. [PubMed] [Google Scholar]
  • 126.Sherrah AG, Vallely MP, Grieve SM, Jeremy RW, Hendel PN, Puranik R. Clinical utility of magnetic resonance imaging in the follow-up of chronic aortic type B dissection. Heart Lung Circ. 2014;23:e157–e159. doi: 10.1016/j.hlc.2014.02.012 [DOI] [PubMed] [Google Scholar]
  • 127.Sherrah AG, Grieve SM, Jeremy RW, Bannon PG, Vallely MP, Puranik R. MRI in chronic aortic dissection: a systematic review and future directions. Front Cardiovasc Med. 2015;2:5. doi: 10.3389/fcvm.2015.00005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Edelman RR, Koktzoglou I. Noncontrast MR angiography: an update. J Magn Reson Imaging. 2019;49:355–373. doi: 10.1002/jmri.26288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Clough RE, Waltham M, Giese D, Taylor PR, Schaeffter T. A new imaging method for assessment of aortic dissection using four-dimensional phase contrast magnetic resonance imaging. J Vasc Surg. 2012;55:914–923. doi: 10.1016/j.jvs.2011.11.005 [DOI] [PubMed] [Google Scholar]
  • 130.Burris NS, Nordsletten DA, Sotelo JA, Grogan-Kaylor R, Houben IB, Figueroa CA, Uribe S, Patel HJ. False lumen ejection fraction predicts growth in type B aortic dissection: preliminary results. Eur J Cardiothorac Surg. 2020;57:896–903. doi: 10.1093/ejcts/ezz343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.François CJ, Markl M, Schiebler ML, Niespodzany E, Landgraf BR, Schlensak C, Frydrychowicz A. Four-dimensional, flow-sensitive magnetic resonance imaging of blood flow patterns in thoracic aortic dissections. J Thorac Cardiovasc Surg. 2013;145:1359–1366. doi: 10.1016/j.jtcvs.2012.07.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Jarvis K, Pruijssen JT, Son AY, Allen BD, Soulat G, Vali A, Barker AJ, Hoel AW, Eskandari MK, Malaisrie SC, et al. Parametric hemodynamic 4D flow MRI maps for the characterization of chronic thoracic descending aortic dissection. J Magn Reson Imaging. 2020;51:1357–1368. doi: 10.1002/jmri.26986 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.de Beaufort HW, Shah DJ, Patel AP, Jackson MS, Spinelli D, Yang EY, Ghosn MG, Autry K, Igo SR, Lumsden AB, et al. Four-dimensional flow cardiovascular magnetic resonance in aortic dissection: assessment in an ex vivo model and preliminary clinical experience. J Thorac Cardiovasc Surg. 2019;157:467–476.e1. doi: 10.1016/j.jtcvs.2018.06.022 [DOI] [PubMed] [Google Scholar]
  • 134.Adriaans BP, Wildberger JE, Westenberg JJM, Lamb HJ, Schalla S. Predictive imaging for thoracic aortic dissection and rupture: moving beyond diameters. Eur Radiol. 2019;29:6396–6404. doi: 10.1007/s00330-019-06320-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Evangelista A, Flachskampf FA, Erbel R, Antonini-Canterin F, Vlachopoulos C, Rocchi G, Sicari R, Nihoyannopoulos P, Zamorano J, Pepi M, et al. ; European Association of Echocardiography; Document Reviewers. Echocardiography in aortic diseases: EAE recommendations for clinical practice. Eur J Echocardiogr. 2010;11:645–658. doi: 10.1093/ejechocard/jeq056 [DOI] [PubMed] [Google Scholar]
  • 136.Evangelista A, Maldonado G, Gruosso D, Gutiérrez L, Granato C, Villalva N, Galian L, González-Alujas T, Teixido G, Rodríguez-Palomares J. The current role of echocardiography in acute aortic syndrome. Echo Res Pract. 2019;6:R53–R63. doi: 10.1530/ERP-18-0058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Evangelista A, Aguilar R, Cuellar H, Thomas M, Laynez A, Rodríguez-Palomares J, Mahía P, Gonzàlez-Alujas T, García-Dorado D. Usefulness of real-time three-dimensional transoesophageal echocardiography in the assessment of chronic aortic dissection. Eur J Echocardiogr. 2011;12:272–277. doi: 10.1093/ejechocard/jeq191 [DOI] [PubMed] [Google Scholar]
  • 138.Roselli EE. Thoracic endovascular aortic repair versus open surgery for type-B chronic dissection. J Thorac Cardiovasc Surg. 2015;149(suppl):S163–S167. doi: 10.1016/j.jtcvs.2014.11.028 [DOI] [PubMed] [Google Scholar]
  • 139.Tagliasacchi A, Delame T, Spagnuolo M, Amenta N, Telea A. 3D skeletons: a state-of-the-art report. Comp Graphics Forum. 2016;35:573–597. doi: 10.1111/cgf.12865 [DOI] [Google Scholar]
  • 140.van Hout MJ, Scholte AJ, Juffermans JF, Westenberg JJ, Zhong L, Zhou X, Schalla SM, Hope MD, Bremerich J, Kramer CM, et al. How to measure the aorta using MRI: a practical guide. J Magn Reson Imaging. 2020;52:971–977. doi: 10.1002/jmri.27183 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Berger JA, Elefteriades JA. Toward uniformity in reporting of thoracic aortic diameter. Int J Angiol. 2012;21:243–244. doi: 10.1055/s-0032-1328968 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Elefteriades JA, Mukherjee SK, Mojibian H. Discrepancies in measurement of the thoracic aorta: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;76:201–217. doi: 10.1016/j.jacc.2020.03.084 [DOI] [PubMed] [Google Scholar]
  • 143.Goldstein SA, Evangelista A, Abbara S, Arai A, Asch FM, Badano LP, Bolen MA, Connolly HM, Cuéllar-Calàbria H, Czerny M, et al. Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:119–182. doi: 10.1016/j.echo.2014.11.015 [DOI] [PubMed] [Google Scholar]
  • 144.Kanitsar A, Fleischmann D, Wegenkittl R, Felkel P, Groller E. CPR: curved planar reformation. IEEE Visualization, 2002;VIS2002:37–44. doi: 10.1109/VISUAL.2002.1183754 [DOI] [Google Scholar]
  • 145.Dugas A, Therasse E, Kauffmann C, Tang A, Elkouri S, Nozza A, Giroux MF, Oliva VL, Soulez G. Reproducibility of abdominal aortic aneurysm diameter measurement and growth evaluation on axial and multiplanar computed tomography reformations. Cardiovasc Intervent Radiol. 2012;35:779–787. doi: 10.1007/s00270-011-0259-y [DOI] [PubMed] [Google Scholar]
  • 146.Bireley WR 2nd, Diniz LO, Groves EM, Dill K, Carroll TJ, Carr JC. Orthogonal measurement of thoracic aorta luminal diameter using ECG-gated high-resolution contrast-enhanced MR angiography. J Magn Reson Imaging. 2007;26:1480–1485. doi: 10.1002/jmri.21085 [DOI] [PubMed] [Google Scholar]
  • 147.Hager A, Kaemmerer H, Rapp-Bernhardt U, Blücher S, Rapp K, Bernhardt TM, Galanski M, Hess J. Diameters of the thoracic aorta throughout life as measured with helical computed tomography. J Thorac Cardiovasc Surg. 2002;123:1060–1066. doi: 10.1067/mtc.2002.122310 [DOI] [PubMed] [Google Scholar]
  • 148.Dillavou ED, Buck DG, Muluk SC, Makaroun MS. Two-dimensional versus three-dimensional CT scan for aortic measurement. J Endovasc Ther. 2003;10:531–538. doi: 10.1177/152660280301000319 [DOI] [PubMed] [Google Scholar]
  • 149.McComb BL, Munden RF, Duan F, Jain AA, Tuite C, Chiles C. Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening Trial. Clin Imaging. 2016;40:936–943. doi: 10.1016/j.clinimag.2016.04.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Ihara T, Komori K, Yamamoto K, Kobayashi M, Banno H, Kodama A. Three-dimensional workstation is useful for measuring the correct size of abdominal aortic aneurysm diameters. Ann Vasc Surg. 2013;27:154–161. doi: 10.1016/j.avsg.2012.03.009 [DOI] [PubMed] [Google Scholar]
  • 151.Mendoza DD, Kochar M, Devereux RB, Basson CT, Min JK, Holmes K, Dietz HC, Milewicz DM, LeMaire SA, Pyeritz RE, Bavaria JE, Maslen CL, Song H, Kroner BL, Eagle KA, Weinsaft JW; GenTAC (National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) Study Investigators. Impact of image analysis methodology on diagnostic and surgical classification of patients with thoracic aortic aneurysms. Ann Thorac Surg. 2011;92:904–912. doi: 10.1016/j.athoracsur.2011.03.130 [DOI] [PubMed] [Google Scholar]
  • 152.Freeman LA, Young PM, Foley TA, Williamson EE, Bruce CJ, Greason KL. CT and MRI assessment of the aortic root and ascending aorta. AJR Am J Roentgenol. 2013;200:W581–W592. doi: 10.2214/AJR.12.9531 [DOI] [PubMed] [Google Scholar]
  • 153.Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39.e14. doi: 10.1016/j.echo.2014.10.003 [DOI] [PubMed] [Google Scholar]
  • 154.Roman MJ, Devereux RB, Kramer-Fox R, O’Loughlin J. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol. 1989;64:507–512. doi: 10.1016/0002-9149(89)90430-x [DOI] [PubMed] [Google Scholar]
  • 155.Vasan RS, Larson MG, Benjamin EJ, Levy D. Echocardiographic reference values for aortic root size: the Framingham Heart Study. J Am Soc Echocardiogr. 1995;8:793–800. doi: 10.1016/s0894-7317(05)80003-3 [DOI] [PubMed] [Google Scholar]
  • 156.Vasan RS, Larson MG, Levy D. Determinants of echocardiographic aortic root size: the Framingham Heart Study. Circulation. 1995;91:734–740. doi: 10.1161/01.cir.91.3.734 [DOI] [PubMed] [Google Scholar]
  • 157.Asch FM, Yuriditsky E, Prakash SK, Roman MJ, Weinsaft JW, Weissman G, Weigold WG, Morris SA, Ravekes WJ, Holmes KW, et al. ; GenTAC Investigators. The need for standardized methods for measuring the aorta: multimodality core lab experience from the GenTAC Registry. JACC Cardiovasc Imaging. 2016;9:219–226. doi: 10.1016/j.jcmg.2015.06.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Green DB, Palumbo MC, Lau C. Imaging of thoracoabdominal aortic aneurysms. J Thorac Imaging. 2018;33:358–365. doi: 10.1097/RTI.0000000000000341 [DOI] [PubMed] [Google Scholar]
  • 159.Lin FY, Devereux RB, Roman MJ, Meng J, Jow VM, Jacobs A, Weinsaft JW, Shaw LJ, Berman DS, Gilmore A, et al. Assessment of the thoracic aorta by multidetector computed tomography: age- and sex-specific reference values in adults without evident cardiovascular disease. J Cardiovasc Comput Tomogr. 2008;2:298–308. doi: 10.1016/j.jcct.2008.08.002 [DOI] [PubMed] [Google Scholar]
  • 160.US Food and Drug Administration. Zenith Alpha thoracic endovascular graft instructions for use. 2015. Accessed January 4, 2022. https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140016d.pdf [Google Scholar]
  • 161.US Food and Drug Administration. Instructions for use for Gore TAG thoracic endoprosthesis. 2013. Accessed January 4, 2022. https://www.accessdata.fda.gov/cdrh_docs/pdf4/P040043S051c.pdf [Google Scholar]
  • 162.Blondheim DS, Vassilenko L, Glick Y, Asif A, Nachtigal A, Meisel SR, Shochat M, Shotan A, Zeina AR. Aortic dimensions by multi-detector computed tomography vs. echocardiography. J Cardiol. 2016;67:365–370. doi: 10.1016/j.jjcc.2015.06.008 [DOI] [PubMed] [Google Scholar]
  • 163.Bons LR, Duijnhouwer AL, Boccalini S, van den Hoven AT, van der Vlugt MJ, Chelu RG, McGhie JS, Kardys I, van den Bosch AE, Siebelink HJ, et al. Intermodality variation of aortic dimensions: how, where and when to measure the ascending aorta. Int J Cardiol. 2019;276:230–235. doi: 10.1016/j.ijcard.2018.08.067 [DOI] [PubMed] [Google Scholar]
  • 164.Frazao C, Tavoosi A, Wintersperger BJ, Nguyen ET, Wald RM, Ouzounian M, Hanneman K. Multimodality assessment of thoracic aortic dimensions: comparison of computed tomography angiography, magnetic resonance imaging, and echocardiography measurements. J Thorac Imaging. 2020;35:399–406. doi: 10.1097/RTI.0000000000000514 [DOI] [PubMed] [Google Scholar]
  • 165.Ghulam Ali S, Fusini L, Dalla Cia A, Tamborini G, Gripari P, Muratori M, Mancini ME, Annoni A, Formenti A, Pepi M. Technological advancements in echocardiographic assessment of thoracic aortic dilatation: head to head comparison among multidetector computed tomography, 2-dimensional, and 3-dimensional echocardiography measurements. J Thorac Imaging. 2018;33:232–239. doi: 10.1097/RTI.0000000000000330 [DOI] [PubMed] [Google Scholar]
  • 166.van der Linde D, Rossi A, Yap SC, McGhie JS, van den Bosch AE, Kirschbaum SW, Russo B, van Dijk AP, Moelker A, Krestin GP, et al. Ascending aortic diameters in congenital aortic stenosis: cardiac magnetic resonance versus transthoracic echocardiography. Echocardiography. 2013;30:497–504. doi: 10.1111/echo.12086 [DOI] [PubMed] [Google Scholar]
  • 167.Rodríguez-Palomares JF, Teixidó-Tura G, Galuppo V, Cuéllar H, Laynez A, Gutiérrez L, González-Alujas MT, García-Dorado D, Evangelista A. Multimodality assessment of ascending aortic diameters: comparison of different measurement methods. J Am Soc Echocardiogr. 2016;29:819–826.e4. doi: 10.1016/j.echo.2016.04.006 [DOI] [PubMed] [Google Scholar]
  • 168.Cayne NS, Veith FJ, Lipsitz EC, Ohki T, Mehta M, Gargiulo N, Suggs WD, Rozenblit A, Ricci Z, Timaran CH. Variability of maximal aortic aneurysm diameter measurements on CT scan: significance and methods to minimize. J Vasc Surg. 2004;39:811–815. doi: 10.1016/j.jvs.2003.11.042 [DOI] [PubMed] [Google Scholar]
  • 169.Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher CW, Messina LM, Ballard DJ, Ansel HJ. Variability in measurement of abdominal aortic aneurysms: Abdominal Aortic Aneurysm Detection and Management Veterans Administration Cooperative Study Group. J Vasc Surg. 1995;21:945–952. doi: 10.1016/s0741-5214(95)70222-9 [DOI] [PubMed] [Google Scholar]
  • 170.Singh K, Jacobsen BK, Solberg S, Bønaa KH, Kumar S, Bajic R, Arnesen E. Intra- and interobserver variability in the measurements of abdominal aortic and common iliac artery diameter with computed tomography: the Tromsø study. Eur J Vasc Endovasc Surg. 2003;25:399–407. doi: 10.1053/ejvs.2002.1856 [DOI] [PubMed] [Google Scholar]
  • 171.Sprouse LR 2nd, Meier GH 3rd, Parent FN, DeMasi RJ, Glickman MH, Barber GA. Is ultrasound more accurate than axial computed tomography for determination of maximal abdominal aortic aneurysm diameter? Eur J Vasc Endovasc Surg. 2004;28:28–35. doi: 10.1016/j.ejvs.2004.03.022 [DOI] [PubMed] [Google Scholar]
  • 172.Paelinck BP, Van Herck PL, Rodrigus I, Claeys MJ, Laborde JC, Parizel PM, Vrints CJ, Bosmans JM. Comparison of magnetic resonance imaging of aortic valve stenosis and aortic root to multimodality imaging for selection of transcatheter aortic valve implantation candidates. Am J Cardiol. 2011;108:92–98. doi: 10.1016/j.amjcard.2011.02.348 [DOI] [PubMed] [Google Scholar]
  • 173.Song JM, Kim SD, Kim JH, Kim MJ, Kang DH, Seo JB, Lim TH, Lee JW, Song MG, Song JK. Long-term predictors of descending aorta aneurysmal change in patients with aortic dissection. J Am Coll Cardiol. 2007;50:799–804. doi: 10.1016/j.jacc.2007.03.064 [DOI] [PubMed] [Google Scholar]
  • 174.Kim KM, Donayre CE, Reynolds TS, Kopchok GE, Walot I, Chauvapun JP, White RA. Aortic remodeling, volumetric analysis, and clinical outcomes of endoluminal exclusion of acute complicated type B thoracic aortic dissections. J Vasc Surg. 2011;54:316–324. doi: 10.1016/j.jvs.2010.11.134 [DOI] [PubMed] [Google Scholar]
  • 175.Elefteriades JA. Thoracic aortic aneurysm: reading the enemy’s playbook. Curr Probl Cardiol. 2008;33:203–277. doi: 10.1016/j.cpcardiol.2008.01.004 [DOI] [PubMed] [Google Scholar]
  • 176.Elefteriades JA, Rizzo JA, Coady MA. Thoracic aorta. Radiology. 1999;211:889. doi: 10.1148/radiology.211.3.r99jn49889 [DOI] [PubMed] [Google Scholar]
  • 177.Schmidt J, Fleischmann D, Preim B, Brandle N, Mistelbauer G. Popup-plots: warping temporal data visualization. IEEE Trans Vis Comput Graph. 2019;25:2443–2457. doi: 10.1109/TVCG.2018.2841385 [DOI] [PubMed] [Google Scholar]
  • 178.Mistelbauer G, Schmidt J, Sailer AM, Baeumler K, Fleischmann D. Aortic dissection maps: comprehensive visualization of aortic dissections for risk assessment. In: Bruckner S, Preim B, Vilanova A, Hauser H, Hennemuth A, Lundervold A. Eurographics Workshop on Visual Computing for Biology and Medicine; Bergen, Norway, 2016. The Eurographics Association. 143–152. doi: 10.2312/vcbm.20161282 [DOI] [Google Scholar]
  • 179.Chiu P, Miller DC. Evolution of surgical therapy for Stanford acute type A aortic dissection. Ann Cardiothorac Surg. 2016;5:275–295. doi: 10.21037/acs.2016.05.05 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 180.Di Bartolomeo R, Pacini D, Savini C, Pilato E, Martin-Suarez S, Di Marco L, Di Eusanio M. Complex thoracic aortic disease: single-stage procedure with the frozen elephant trunk technique. J Thorac Cardiovasc Surg. 2010;140(suppl):S81–S85. doi: 10.1016/j.jtcvs.2010.07.039 [DOI] [PubMed] [Google Scholar]
  • 181.Sueyoshi E, Nagayama H, Hayashida T, Sakamoto I, Uetani M. Fate of aorta and clinical outcomes in patients with chronic type B aortic dissection: over 20-year experience. J Cardiovasc Surg (Torino). 2014;55:247–255. [PubMed] [Google Scholar]
  • 182.Cooper DG, Walsh SR, Sadat U, Noorani A, Hayes PD, Boyle JR. Neurological complications after left subclavian artery coverage during thoracic endovascular aortic repair: a systematic review and meta-analysis. J Vasc Surg. 2009;49:1594–1601. doi: 10.1016/j.jvs.2008.12.075 [DOI] [PubMed] [Google Scholar]
  • 183.Walsh SR, Tang TY, Sadat U, Naik J, Gaunt ME, Boyle JR, Hayes PD, Varty K. Endovascular stenting versus open surgery for thoracic aortic disease: systematic review and meta-analysis of perioperative results. J Vasc Surg. 2008;47:1094–1098. doi: 10.1016/j.jvs.2007.09.062 [DOI] [PubMed] [Google Scholar]
  • 184.Wong CS, Healy D, Canning C, Coffey JC, Boyle JR, Walsh SR. A systematic review of spinal cord injury and cerebrospinal fluid drainage after thoracic aortic endografting. J Vasc Surg. 2012;56:1438–1447. doi: 10.1016/j.jvs.2012.05.075 [DOI] [PubMed] [Google Scholar]
  • 185.Hahn LD, Mistelbauer G, Higashigaito K, Koci M, Willemink MJ, Sailer AM, Fischbein M, Fleischmann D. CT-based true- and false-lumen segmentation in type B aortic dissection using machine learning. Radiol Cardiothorac Imaging. 2020;2:e190179. doi: 10.1148/ryct.2020190179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 186.Higashigaito K, Sailer AM, van Kuijk SMJ, Willemink MJ, Hahn LD, Hastie TJ, Miller DC, Fischbein MP, Fleischmann D. Aortic growth and development of partial false lumen thrombosis are associated with late adverse events in type B aortic dissection. J Thorac Cardiovasc Surg. 2021;161:1184–1190.e2. doi: 10.1016/j.jtcvs.2019.10.074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 187.Czerny M, Stöhr S, Aymard T, Sodeck GH, Ehrlich M, Dziodzio T, Juraszek A, Carrel T. Effect on false-lumen status of a combined vascular and endovascular approach for the treatment of acute type A aortic dissection. Eur J Cardiothorac Surg. 2012;41:409–413. doi: 10.1016/j.ejcts.2011.05.063 [DOI] [PubMed] [Google Scholar]
  • 188.Bozso SJ, Nagendran J, MacArthur RGG, Chu MWA, Kiaii B, El-Hamamsy I, Cartier R, Shahriari A, Moon MC. Dissected aorta repair through stent implantation trial: Canadian results. J Thorac Cardiovasc Surg. 2019;157:1763–1771. doi: 10.1016/j.jtcvs.2018.09.120 [DOI] [PubMed] [Google Scholar]
  • 189.Nienaber CA, Kische S, Zeller T, Rehders TC, Schneider H, Lorenzen B, Bünger C, Ince H. Provisional extension to induce complete attachment after stent-graft placement in type B aortic dissection: the PETTICOAT concept. J Endovasc Ther. 2006;13:738–746. doi: 10.1583/06-1923.1 [DOI] [PubMed] [Google Scholar]
  • 190.Armour CH, Menichini C, Milinis K, Gibbs RGJ, Xu XY. Location of reentry tears affects false lumen thrombosis in aortic dissection following TEVAR. J Endovasc Ther. 2020;27:396–404. doi: 10.1177/1526602820917962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 191.Menichini C, Cheng Z, Gibbs RGJ, Xu XY. A computational model for false lumen thrombosis in type B aortic dissection following thoracic endovascular repair. J Biomech. 2018;66:36–43. doi: 10.1016/j.jbiomech.2017.10.029 [DOI] [PubMed] [Google Scholar]
  • 192.Cao L, Shi R, Ge Y, Xing L, Zuo P, Jia Y, Liu J, He Y, Wang X, Luan S, et al. Fully automatic segmentation of type B aortic dissection from CTA images enabled by deep learning. Eur J Radiol. 2019;121:108713. doi: 10.1016/j.ejrad.2019.108713 [DOI] [PubMed] [Google Scholar]
  • 193.Codari M, Pepe A, Mistelbauer G, Mastrodicasa D, Walters S, Willemink M, Fleischmann D. Deep reinforcement learning for localization of the aortic annulus in patients with aortic dissection. In: Petersen J, San Jose Estepar R, Schmidt-Richberg A, Gerard S, Lassen-Schmidt B, Jacobs C, Beichel R, Mori K. eds. Thoracic Image Analysis. Switzerland: Springer; 2020:94–105. doi: 10.1007/978-3-030-62469-9_9 [DOI] [Google Scholar]
  • 194.Wojnarski CM, Svensson LG, Roselli EE, Idrees JJ, Lowry AM, Ehrlinger J, Pettersson GB, Gillinov AM, Johnston DR, Soltesz EG, et al. Aortic dissection in patients with bicuspid aortic valve-associated aneurysms. Ann Thorac Surg. 2015;100:1666–1673. doi: 10.1016/j.athoracsur.2015.04.126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 195.Lee R, Jarchi D, Perera R, Jones A, Cassimjee I, Handa A, Clifton DA; Oxford Abdominal Aortic Aneurysm Study and Oxford Regional Vascular Service. Applied machine learning for the prediction of growth of abdominal aortic aneurysm in humans. EJVES Short Rep. 2018;39:24–28. doi: 10.1016/j.ejvssr.2018.03.004 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Video 1
Download video file (529.3KB, mov)
Supplemental Figures

RESOURCES